<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:podcast="https://podcastindex.org/namespace/1.0">
  <channel>
    <atom:link href="https://feeds.simplecast.com/CC7kJR0I" rel="self" title="MP3 Audio" type="application/atom+xml"/>
    <atom:link href="https://simplecast.superfeedr.com" rel="hub" xmlns="http://www.w3.org/2005/Atom"/>
    <generator>https://simplecast.com</generator>
    <title>Vital Signs with Jacob Effron and Nikhil Krishnan</title>
    <description>On Vital Signs, Jacob Effron and Nikhil Krishnan dig into cutting-edge trends in healthtech and the people shaping them. Every two weeks they’ll explore a new sub-sector and trend with policy leaders, startup founders and industry executives. 
Subscribe now to make sure you don’t miss any of it!</description>
    <copyright>2022</copyright>
    <language>en</language>
    <pubDate>Wed, 7 Jan 2026 14:05:01 +0000</pubDate>
    <lastBuildDate>Wed, 7 Jan 2026 14:05:12 +0000</lastBuildDate>
    <image>
      <link>https://vital-signs-e526bbac.simplecast.com</link>
      <title>Vital Signs with Jacob Effron and Nikhil Krishnan</title>
      <url>https://image.simplecastcdn.com/images/ff0dbf2f-5711-4964-9172-807c39ca4824/7e3d553a-fe25-4ad8-85fb-31c03078a29c/3000x3000/redpoint-vital-signs-logo-01.jpg?aid=rss_feed</url>
    </image>
    <link>https://vital-signs-e526bbac.simplecast.com</link>
    <itunes:type>episodic</itunes:type>
    <itunes:summary>On Vital Signs, Jacob Effron and Nikhil Krishnan dig into cutting-edge trends in healthtech and the people shaping them. Every two weeks they’ll explore a new sub-sector and trend with policy leaders, startup founders and industry executives. 
Subscribe now to make sure you don’t miss any of it!</itunes:summary>
    <itunes:author>by Redpoint Ventures</itunes:author>
    <itunes:explicit>false</itunes:explicit>
    <itunes:image href="https://image.simplecastcdn.com/images/ff0dbf2f-5711-4964-9172-807c39ca4824/7e3d553a-fe25-4ad8-85fb-31c03078a29c/3000x3000/redpoint-vital-signs-logo-01.jpg?aid=rss_feed"/>
    <itunes:new-feed-url>https://feeds.simplecast.com/CC7kJR0I</itunes:new-feed-url>
    <itunes:keywords>business, health-tech, healthcare, healthtech, redpoint ventures, venture, venture capital</itunes:keywords>
    <itunes:owner>
      <itunes:name>Redpoint Ventures</itunes:name>
      <itunes:email>jeffron@redpoint.com</itunes:email>
    </itunes:owner>
    <itunes:category text="Business">
      <itunes:category text="Investing"/>
    </itunes:category>
    <item>
      <guid isPermaLink="false">6cf3e548-7936-4c9c-88d1-d73752564997</guid>
      <title>Ep 66: Pete Shalek On The Future of Front Office Automation</title>
      <description><![CDATA[<p>Pete Shalek, founder of Valerie Health, is a multi-time healthcare entrepreneur who previously founded Joyable in 2013 (one of the earliest digital mental health platforms) and served as Chief Product Officer at AbleTo and Stellar Health. Pete discusses why AI in healthcare needs to move beyond selling software tools to actually doing the work for providers. He shares hard-won lessons from a decade in digital health, including why the shift to quality-based care in behavioral health has been surprisingly slow and why Joyable's therapist-free model was ahead of its time relative to payment models. The conversation covers Valerie's approach of building an AI front office that handles referrals, scheduling, and intake for independent medical practices without requiring them to learn new software, achieving 3-4 week implementations and 5-7% conversion lifts. Pete explains the technical challenges of structuring unstructured healthcare data with 100% accuracy, the strategic choice to own operations end-to-end rather than just provide tools, why referrals are the perfect wedge product as the most upstream data point, and his evolving views on how quickly AI will impact the gray area between administrative and clinical work. Throughout, he emphasizes the importance of meeting healthcare where it is (turning faxes into structured data rather than trying to force system-wide transformation) and building for today's payment models while working toward a bigger vision.</p><p> </p><p>(0:00) Intro<br />(0:52) Pete's Journey in Digital Health<br />(1:45) Challenges in Behavioral Health<br />(3:38) Valerie Health: An AI Front Office<br />(4:47) Valerie's Unique Approach to Software<br />(6:16) Customer-Centric Solutions<br />(8:38) Data and AI in Healthcare<br />(10:19) Building a Successful Health Tech Company<br />(13:19) Future of AI in Healthcare<br />(16:16) Operational Challenges and Solutions<br />(28:57) Pricing and Value Delivery<br />(30:12) Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Wed, 7 Jan 2026 14:05:01 +0000</pubDate>
      <author>jeffron@redpoint.com (Pete Shalek, Meera Clark, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-66-pete-shalek-on-the-future-of-front-office-automation-dE_reT66</link>
      <content:encoded><![CDATA[<p>Pete Shalek, founder of Valerie Health, is a multi-time healthcare entrepreneur who previously founded Joyable in 2013 (one of the earliest digital mental health platforms) and served as Chief Product Officer at AbleTo and Stellar Health. Pete discusses why AI in healthcare needs to move beyond selling software tools to actually doing the work for providers. He shares hard-won lessons from a decade in digital health, including why the shift to quality-based care in behavioral health has been surprisingly slow and why Joyable's therapist-free model was ahead of its time relative to payment models. The conversation covers Valerie's approach of building an AI front office that handles referrals, scheduling, and intake for independent medical practices without requiring them to learn new software, achieving 3-4 week implementations and 5-7% conversion lifts. Pete explains the technical challenges of structuring unstructured healthcare data with 100% accuracy, the strategic choice to own operations end-to-end rather than just provide tools, why referrals are the perfect wedge product as the most upstream data point, and his evolving views on how quickly AI will impact the gray area between administrative and clinical work. Throughout, he emphasizes the importance of meeting healthcare where it is (turning faxes into structured data rather than trying to force system-wide transformation) and building for today's payment models while working toward a bigger vision.</p><p> </p><p>(0:00) Intro<br />(0:52) Pete's Journey in Digital Health<br />(1:45) Challenges in Behavioral Health<br />(3:38) Valerie Health: An AI Front Office<br />(4:47) Valerie's Unique Approach to Software<br />(6:16) Customer-Centric Solutions<br />(8:38) Data and AI in Healthcare<br />(10:19) Building a Successful Health Tech Company<br />(13:19) Future of AI in Healthcare<br />(16:16) Operational Challenges and Solutions<br />(28:57) Pricing and Value Delivery<br />(30:12) Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="33915392" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/34b56ac6-f272-43d6-a333-541420083e22/audio/10a4ff5f-e969-406f-8ea2-370cf14755fc/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 66: Pete Shalek On The Future of Front Office Automation</itunes:title>
      <itunes:author>Pete Shalek, Meera Clark, Jacob Effron</itunes:author>
      <itunes:duration>00:35:19</itunes:duration>
      <itunes:summary>Pete Shalek, founder of Valerie Health, is a multi-time healthcare entrepreneur who previously founded Joyable in 2013 (one of the earliest digital mental health platforms) and served as Chief Product Officer at AbleTo and Stellar Health. Pete discusses why AI in healthcare needs to move beyond selling software tools to actually doing the work for providers. He shares hard-won lessons from a decade in digital health, including why the shift to quality-based care in behavioral health has been surprisingly slow and why Joyable&apos;s therapist-free model was ahead of its time relative to payment models. The conversation covers Valerie&apos;s approach of building an AI front office that handles referrals, scheduling, and intake for independent medical practices without requiring them to learn new software, achieving 3-4 week implementations and 5-7% conversion lifts. Pete explains the technical challenges of structuring unstructured healthcare data with 100% accuracy, the strategic choice to own operations end-to-end rather than just provide tools, why referrals are the perfect wedge product as the most upstream data point, and his evolving views on how quickly AI will impact the gray area between administrative and clinical work. Throughout, he emphasizes the importance of meeting healthcare where it is (turning faxes into structured data rather than trying to force system-wide transformation) and building for today&apos;s payment models while working toward a bigger vision.</itunes:summary>
      <itunes:subtitle>Pete Shalek, founder of Valerie Health, is a multi-time healthcare entrepreneur who previously founded Joyable in 2013 (one of the earliest digital mental health platforms) and served as Chief Product Officer at AbleTo and Stellar Health. Pete discusses why AI in healthcare needs to move beyond selling software tools to actually doing the work for providers. He shares hard-won lessons from a decade in digital health, including why the shift to quality-based care in behavioral health has been surprisingly slow and why Joyable&apos;s therapist-free model was ahead of its time relative to payment models. The conversation covers Valerie&apos;s approach of building an AI front office that handles referrals, scheduling, and intake for independent medical practices without requiring them to learn new software, achieving 3-4 week implementations and 5-7% conversion lifts. Pete explains the technical challenges of structuring unstructured healthcare data with 100% accuracy, the strategic choice to own operations end-to-end rather than just provide tools, why referrals are the perfect wedge product as the most upstream data point, and his evolving views on how quickly AI will impact the gray area between administrative and clinical work. Throughout, he emphasizes the importance of meeting healthcare where it is (turning faxes into structured data rather than trying to force system-wide transformation) and building for today&apos;s payment models while working toward a bigger vision.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>66</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6ef0c8d3-6c15-4b40-ba0e-92fbf29388f8</guid>
      <title>Ep 65: CMMI Leaders on ACCESS Model Launch, Drug Pricing Strategy, and the Future of Technology Enabled Care</title>
      <description><![CDATA[<p>This episode announces the launch of CMS's ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model - a groundbreaking payment innovation that enables technology-enabled care organizations to treat Medicare fee-for-service patients with chronic conditions through outcome-aligned payments rather than traditional fee-for-service. Abe Sutton (Director of CMMI) and Jacob Shiff (Chief AI & Technology Officer at CMMI) explain how the model addresses a fundamental gap in healthcare: while commercial and Medicare Advantage patients have access to digital therapeutics and technology-enabled chronic disease management, original Medicare beneficiaries have been left behind. ACCESS changes this by paying providers monthly fees for managing conditions like diabetes, hypertension, obesity, behavioral health issues, and musculoskeletal pain - but only when patients achieve measurable clinical improvements. The model is designed to be deflationary rather than inflationary, encourages innovation by simplifying go-to-market for digital health startups, integrates with existing risk-bearing models like ACOs, and represents a broader CMMI strategy to shift from activity-based to outcome-based payments while leveraging new AI capabilities to democratize high-quality care.</p><p> </p><p>(0:00) Intro<br />(0:57) The ACCESS Model: Advancing Chronic Care<br />(4:35) Outcome-Aligned Payments and Technology<br />(7:40) Encouraging Innovation and Investment<br />(09:23) Practical Implementation and Examples<br />(24:28) Evaluating Success and Future Goals<br />(26:18) Connecting the Dots: Broader CMMI Initiatives<br />(28:40) Generous and Its Impact on Drug Pricing<br />(30:11) Challenges and Benefits of Prior Authorization<br />(35:19) The Role of Technology in Healthcare<br />(37:59) AI and Technology-Enabled Care<br />(40:26) Reflections on Value-Based Care Models<br />(43:51) Encouraging Competition in the Healthcare Market<br />(48:24) Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Mon, 8 Dec 2025 13:55:09 +0000</pubDate>
      <author>jeffron@redpoint.com (Abe Sutton, Jacob Shiff, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-65-cmmi-leaders-on-access-model-launch-drug-pricing-strategy-and-the-future-of-technology-enabled-care-jTkvMHE1</link>
      <content:encoded><![CDATA[<p>This episode announces the launch of CMS's ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model - a groundbreaking payment innovation that enables technology-enabled care organizations to treat Medicare fee-for-service patients with chronic conditions through outcome-aligned payments rather than traditional fee-for-service. Abe Sutton (Director of CMMI) and Jacob Shiff (Chief AI & Technology Officer at CMMI) explain how the model addresses a fundamental gap in healthcare: while commercial and Medicare Advantage patients have access to digital therapeutics and technology-enabled chronic disease management, original Medicare beneficiaries have been left behind. ACCESS changes this by paying providers monthly fees for managing conditions like diabetes, hypertension, obesity, behavioral health issues, and musculoskeletal pain - but only when patients achieve measurable clinical improvements. The model is designed to be deflationary rather than inflationary, encourages innovation by simplifying go-to-market for digital health startups, integrates with existing risk-bearing models like ACOs, and represents a broader CMMI strategy to shift from activity-based to outcome-based payments while leveraging new AI capabilities to democratize high-quality care.</p><p> </p><p>(0:00) Intro<br />(0:57) The ACCESS Model: Advancing Chronic Care<br />(4:35) Outcome-Aligned Payments and Technology<br />(7:40) Encouraging Innovation and Investment<br />(09:23) Practical Implementation and Examples<br />(24:28) Evaluating Success and Future Goals<br />(26:18) Connecting the Dots: Broader CMMI Initiatives<br />(28:40) Generous and Its Impact on Drug Pricing<br />(30:11) Challenges and Benefits of Prior Authorization<br />(35:19) The Role of Technology in Healthcare<br />(37:59) AI and Technology-Enabled Care<br />(40:26) Reflections on Value-Based Care Models<br />(43:51) Encouraging Competition in the Healthcare Market<br />(48:24) Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="54637392" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/d6c35f2d-205c-45c1-bc23-fb24b056fa1f/audio/b5b8d7b7-d16d-4486-ad81-750d966adefe/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 65: CMMI Leaders on ACCESS Model Launch, Drug Pricing Strategy, and the Future of Technology Enabled Care</itunes:title>
      <itunes:author>Abe Sutton, Jacob Shiff, Jacob Effron</itunes:author>
      <itunes:duration>00:56:54</itunes:duration>
      <itunes:summary>This episode announces the launch of CMS&apos;s ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model - a groundbreaking payment innovation that enables technology-enabled care organizations to treat Medicare fee-for-service patients with chronic conditions through outcome-aligned payments rather than traditional fee-for-service. Abe Sutton (Director of CMMI) and Jacob Shiff (Chief AI &amp; Technology Officer at CMMI) explain how the model addresses a fundamental gap in healthcare: while commercial and Medicare Advantage patients have access to digital therapeutics and technology-enabled chronic disease management, original Medicare beneficiaries have been left behind. ACCESS changes this by paying providers monthly fees for managing conditions like diabetes, hypertension, obesity, behavioral health issues, and musculoskeletal pain - but only when patients achieve measurable clinical improvements. The model is designed to be deflationary rather than inflationary, encourages innovation by simplifying go-to-market for digital health startups, integrates with existing risk-bearing models like ACOs, and represents a broader CMMI strategy to shift from activity-based to outcome-based payments while leveraging new AI capabilities to democratize high-quality care.</itunes:summary>
      <itunes:subtitle>This episode announces the launch of CMS&apos;s ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model - a groundbreaking payment innovation that enables technology-enabled care organizations to treat Medicare fee-for-service patients with chronic conditions through outcome-aligned payments rather than traditional fee-for-service. Abe Sutton (Director of CMMI) and Jacob Shiff (Chief AI &amp; Technology Officer at CMMI) explain how the model addresses a fundamental gap in healthcare: while commercial and Medicare Advantage patients have access to digital therapeutics and technology-enabled chronic disease management, original Medicare beneficiaries have been left behind. ACCESS changes this by paying providers monthly fees for managing conditions like diabetes, hypertension, obesity, behavioral health issues, and musculoskeletal pain - but only when patients achieve measurable clinical improvements. The model is designed to be deflationary rather than inflationary, encourages innovation by simplifying go-to-market for digital health startups, integrates with existing risk-bearing models like ACOs, and represents a broader CMMI strategy to shift from activity-based to outcome-based payments while leveraging new AI capabilities to democratize high-quality care.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>65</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c62039f7-e961-44ce-8ee7-c0056fbdccdc</guid>
      <title>Ep 64: Sutter Health CEO &amp; President Warner Thomas on Digital Transformation and the Future of Health Systems</title>
      <description><![CDATA[<p>The episode explores how Warner Thomas is transforming Sutter Health into a digitally-enabled, ambulatory-focused health system that can navigate major industry headwinds through growth rather than contraction. Thomas discusses Sutter's aggressive expansion of its physician network and ambulatory footprint, the system's push to dramatically improve consumer experience through technologies like online booking and ambient AI documentation, and their strategic pivot toward value-based care models as Medicare payment pressures intensify. Throughout the conversation, he emphasizes that successful health systems must embrace AI and digital tools not as futuristic concepts but as immediate operational necessities, while maintaining focus on integrated care delivery that keeps patients at the center—a philosophy shaped by his experience building integrated systems at Ochsner and now applied to reimagining Sutter's historically hospital-centric culture into one that blends physical and digital care delivery across the full continuum.</p><p> </p><p>(0:00) Intro<br />(1:01) Overview of Sutter Health<br />(1:56) Comparing Sutter Health and Ochsner<br />(4:08) Key Focus Areas for Sutter Health<br />(6:49) Consumer Experience and Technology Integration<br />(10:56) The Role of AI in Healthcare<br />(18:03) Advice for Startups in Health Tech<br />(21:19) Navigating Financial Challenges in Healthcare<br />(24:23) Healthcare Policy and Advocacy<br />(25:59) Competition and Differentiation in Healthcare<br />(29:58) Value-Based Care and Medicare<br />(34:03) Quickfire</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></description>
      <pubDate>Fri, 7 Nov 2025 14:35:56 +0000</pubDate>
      <author>jeffron@redpoint.com (Warner Thomas, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-64-sutter-health-ceo-president-warner-thomas-on-digital-transformation-and-the-future-of-health-systems-LOtkVsda</link>
      <content:encoded><![CDATA[<p>The episode explores how Warner Thomas is transforming Sutter Health into a digitally-enabled, ambulatory-focused health system that can navigate major industry headwinds through growth rather than contraction. Thomas discusses Sutter's aggressive expansion of its physician network and ambulatory footprint, the system's push to dramatically improve consumer experience through technologies like online booking and ambient AI documentation, and their strategic pivot toward value-based care models as Medicare payment pressures intensify. Throughout the conversation, he emphasizes that successful health systems must embrace AI and digital tools not as futuristic concepts but as immediate operational necessities, while maintaining focus on integrated care delivery that keeps patients at the center—a philosophy shaped by his experience building integrated systems at Ochsner and now applied to reimagining Sutter's historically hospital-centric culture into one that blends physical and digital care delivery across the full continuum.</p><p> </p><p>(0:00) Intro<br />(1:01) Overview of Sutter Health<br />(1:56) Comparing Sutter Health and Ochsner<br />(4:08) Key Focus Areas for Sutter Health<br />(6:49) Consumer Experience and Technology Integration<br />(10:56) The Role of AI in Healthcare<br />(18:03) Advice for Startups in Health Tech<br />(21:19) Navigating Financial Challenges in Healthcare<br />(24:23) Healthcare Policy and Advocacy<br />(25:59) Competition and Differentiation in Healthcare<br />(29:58) Value-Based Care and Medicare<br />(34:03) Quickfire</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></content:encoded>
      <enclosure length="42816242" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/0b07df2e-4edf-4c8e-9185-e27d3e493f81/audio/ee212a1b-61dd-4d8e-8c90-5abbfd262a2a/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 64: Sutter Health CEO &amp; President Warner Thomas on Digital Transformation and the Future of Health Systems</itunes:title>
      <itunes:author>Warner Thomas, Jacob Effron</itunes:author>
      <itunes:duration>00:44:35</itunes:duration>
      <itunes:summary>The episode explores how Warner Thomas is transforming Sutter Health into a digitally-enabled, ambulatory-focused health system that can navigate major industry headwinds through growth rather than contraction. Thomas discusses Sutter&apos;s aggressive expansion of its physician network and ambulatory footprint, the system&apos;s push to dramatically improve consumer experience through technologies like online booking and ambient AI documentation, and their strategic pivot toward value-based care models as Medicare payment pressures intensify. Throughout the conversation, he emphasizes that successful health systems must embrace AI and digital tools not as futuristic concepts but as immediate operational necessities, while maintaining focus on integrated care delivery that keeps patients at the center—a philosophy shaped by his experience building integrated systems at Ochsner and now applied to reimagining Sutter&apos;s historically hospital-centric culture into one that blends physical and digital care delivery across the full continuum.</itunes:summary>
      <itunes:subtitle>The episode explores how Warner Thomas is transforming Sutter Health into a digitally-enabled, ambulatory-focused health system that can navigate major industry headwinds through growth rather than contraction. Thomas discusses Sutter&apos;s aggressive expansion of its physician network and ambulatory footprint, the system&apos;s push to dramatically improve consumer experience through technologies like online booking and ambient AI documentation, and their strategic pivot toward value-based care models as Medicare payment pressures intensify. Throughout the conversation, he emphasizes that successful health systems must embrace AI and digital tools not as futuristic concepts but as immediate operational necessities, while maintaining focus on integrated care delivery that keeps patients at the center—a philosophy shaped by his experience building integrated systems at Ochsner and now applied to reimagining Sutter&apos;s historically hospital-centric culture into one that blends physical and digital care delivery across the full continuum.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>64</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">61c8c6bd-ac80-4e39-8e17-7123601f04ac</guid>
      <title>Ep 63: Narayana Health Vice Chairman on Scaling Quality Care in India and Tech’s Role</title>
      <description><![CDATA[<p>This episode features Viren Shetty, Vice Chairman of Narayana Health, discussing how his father founded a cardiac surgery hospital in India 25 years ago that revolutionized healthcare delivery by applying manufacturing efficiency principles to drastically reduce costs while maintaining quality. The conversation explores how Narayana Health scaled from one cardiac center to 19 multi-specialty hospitals across India and one in the Cayman Islands by implementing supply chain optimization, standardization of care, physician specialization, and high-volume operations—enabling them to perform cardiac surgeries at a fraction of Western costs. Shetty discusses the challenges and opportunities of operating in India's largely out-of-pocket healthcare market, the hospital's expansion into insurance and primary care to become a fully integrated provider, their measured approach to AI adoption, and why their high-volume, efficiency-driven model wouldn't directly translate to the US healthcare system despite offering valuable lessons in operational excellence and cost reduction.</p><p> </p><p>(0:00) Intro</p><p>(1:20) Founding and Growth of Narayana Health</p><p>(2:48) Cost Reduction Strategies in Indian Healthcare</p><p>(6:04) Challenges and Cultural Shifts in Standardization</p><p>(8:16) Scaling and Expansion Bottlenecks</p><p>(14:10) Impact of COVID-19 on Narayana Health</p><p>(19:15) Medical Tourism and the Cayman Islands</p><p>(23:03) High Patient Volume in Indian Hospitals</p><p>(24:29) Exploring Healthcare Ecosystems</p><p>(25:25) Automating Healthcare Administration</p><p>(26:39) Challenges in US Healthcare</p><p>(28:18) Innovative Healthcare Models</p><p>(30:28) AI in Medicine</p><p>(33:22) Driving Efficiency in Hospitals</p><p>(37:48) Opportunities in Indian Healthcare</p><p>(40:34) Quickfire</p><p> </p><p>With your co-hosts: </p><p>@jacobeffron </p><p>- Partner at Redpoint, Former PM Flatiron Health </p><p>@patrickachase </p><p>- Partner at Redpoint, Former ML Engineer LinkedIn </p><p>@ericabrescia </p><p>- Former COO Github, Founder Bitnami (acq’d by VMWare) </p><p>@jordan_segall </p><p>- Partner at Redpoint</p>
]]></description>
      <pubDate>Wed, 1 Oct 2025 12:57:13 +0000</pubDate>
      <author>jeffron@redpoint.com (Viren Shetty, Jacob Effron, Nikhil Krishnan)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-63-narayana-health-vice-chairman-on-scaling-quality-care-in-india-and-techs-role-7zmFq0eS</link>
      <content:encoded><![CDATA[<p>This episode features Viren Shetty, Vice Chairman of Narayana Health, discussing how his father founded a cardiac surgery hospital in India 25 years ago that revolutionized healthcare delivery by applying manufacturing efficiency principles to drastically reduce costs while maintaining quality. The conversation explores how Narayana Health scaled from one cardiac center to 19 multi-specialty hospitals across India and one in the Cayman Islands by implementing supply chain optimization, standardization of care, physician specialization, and high-volume operations—enabling them to perform cardiac surgeries at a fraction of Western costs. Shetty discusses the challenges and opportunities of operating in India's largely out-of-pocket healthcare market, the hospital's expansion into insurance and primary care to become a fully integrated provider, their measured approach to AI adoption, and why their high-volume, efficiency-driven model wouldn't directly translate to the US healthcare system despite offering valuable lessons in operational excellence and cost reduction.</p><p> </p><p>(0:00) Intro</p><p>(1:20) Founding and Growth of Narayana Health</p><p>(2:48) Cost Reduction Strategies in Indian Healthcare</p><p>(6:04) Challenges and Cultural Shifts in Standardization</p><p>(8:16) Scaling and Expansion Bottlenecks</p><p>(14:10) Impact of COVID-19 on Narayana Health</p><p>(19:15) Medical Tourism and the Cayman Islands</p><p>(23:03) High Patient Volume in Indian Hospitals</p><p>(24:29) Exploring Healthcare Ecosystems</p><p>(25:25) Automating Healthcare Administration</p><p>(26:39) Challenges in US Healthcare</p><p>(28:18) Innovative Healthcare Models</p><p>(30:28) AI in Medicine</p><p>(33:22) Driving Efficiency in Hospitals</p><p>(37:48) Opportunities in Indian Healthcare</p><p>(40:34) Quickfire</p><p> </p><p>With your co-hosts: </p><p>@jacobeffron </p><p>- Partner at Redpoint, Former PM Flatiron Health </p><p>@patrickachase </p><p>- Partner at Redpoint, Former ML Engineer LinkedIn </p><p>@ericabrescia </p><p>- Former COO Github, Founder Bitnami (acq’d by VMWare) </p><p>@jordan_segall </p><p>- Partner at Redpoint</p>
]]></content:encoded>
      <enclosure length="44634740" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/e200694e-6906-4c5e-9555-941ff123d1ac/audio/b0888877-8ac2-4733-bf79-69b053430b8c/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 63: Narayana Health Vice Chairman on Scaling Quality Care in India and Tech’s Role</itunes:title>
      <itunes:author>Viren Shetty, Jacob Effron, Nikhil Krishnan</itunes:author>
      <itunes:duration>00:46:29</itunes:duration>
      <itunes:summary>This episode features Viren Shetty, Vice Chairman of Narayana Health, discussing how his father founded a cardiac surgery hospital in India 25 years ago that revolutionized healthcare delivery by applying manufacturing efficiency principles to drastically reduce costs while maintaining quality. The conversation explores how Narayana Health scaled from one cardiac center to 19 multi-specialty hospitals across India and one in the Cayman Islands by implementing supply chain optimization, standardization of care, physician specialization, and high-volume operations—enabling them to perform cardiac surgeries at a fraction of Western costs. Shetty discusses the challenges and opportunities of operating in India&apos;s largely out-of-pocket healthcare market, the hospital&apos;s expansion into insurance and primary care to become a fully integrated provider, their measured approach to AI adoption, and why their high-volume, efficiency-driven model wouldn&apos;t directly translate to the US healthcare system despite offering valuable lessons in operational excellence and cost reduction.</itunes:summary>
      <itunes:subtitle>This episode features Viren Shetty, Vice Chairman of Narayana Health, discussing how his father founded a cardiac surgery hospital in India 25 years ago that revolutionized healthcare delivery by applying manufacturing efficiency principles to drastically reduce costs while maintaining quality. The conversation explores how Narayana Health scaled from one cardiac center to 19 multi-specialty hospitals across India and one in the Cayman Islands by implementing supply chain optimization, standardization of care, physician specialization, and high-volume operations—enabling them to perform cardiac surgeries at a fraction of Western costs. Shetty discusses the challenges and opportunities of operating in India&apos;s largely out-of-pocket healthcare market, the hospital&apos;s expansion into insurance and primary care to become a fully integrated provider, their measured approach to AI adoption, and why their high-volume, efficiency-driven model wouldn&apos;t directly translate to the US healthcare system despite offering valuable lessons in operational excellence and cost reduction.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>63</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f4592b6a-436a-4c7c-b5f7-f066aec2869d</guid>
      <title>Ep 62: Merck KGaA Chief Data and AI Officer on Scaling AI in Pharma and The Future of Enterprise Software</title>
      <description><![CDATA[<p>This episode captures Walid Mehanna's perspective on how Merck KGaA has approached enterprise AI adoption through a federated strategy that prioritizes people over technology. The core message is that successful AI implementation requires building organizational capability across three dimensions - people, processes, and technology - rather than seeking a single transformative solution. Walid argues that companies must establish a broad foundation of AI literacy (exemplified by their internal MyGPT tool reaching 25,000 users) before pursuing specialized applications, while maintaining human accountability to prevent complacency. He emphasizes that AI works best when it's treated as an experimental, iterative capability distributed across the organization rather than controlled centrally, with success depending on persistence through the inevitable J-curve of initial productivity drops. The conversation reveals how a large multinational navigates the practical realities of AI deployment - from managing regulatory complexity across different geographies to making pragmatic build-versus-buy decisions - while maintaining focus on the fundamental principle that AI should augment human expertise rather than replace human judgment and responsibility.</p><p> </p><p>(0:00) Intro<br />(0:29) How AI is Used at Merck<br />(2:18) AI Applications Across the Value Chain<br />(4:31) Challenges and Risks of AI Implementation<br />(5:35) Federated Approach to AI Prioritization<br />(6:44) Future AI Use Cases and Data Challenges<br />(10:38) Building and Partnering for AI Solutions<br />(15:11) AI in Drug Discovery and R&D<br />(26:47) Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Mon, 29 Sep 2025 12:55:26 +0000</pubDate>
      <author>jeffron@redpoint.com (Walid Mehanna, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-62-merck-kgaa-chief-data-and-ai-officer-on-scaling-ai-in-pharma-and-the-future-of-enterprise-software-Oi2vQMvv</link>
      <content:encoded><![CDATA[<p>This episode captures Walid Mehanna's perspective on how Merck KGaA has approached enterprise AI adoption through a federated strategy that prioritizes people over technology. The core message is that successful AI implementation requires building organizational capability across three dimensions - people, processes, and technology - rather than seeking a single transformative solution. Walid argues that companies must establish a broad foundation of AI literacy (exemplified by their internal MyGPT tool reaching 25,000 users) before pursuing specialized applications, while maintaining human accountability to prevent complacency. He emphasizes that AI works best when it's treated as an experimental, iterative capability distributed across the organization rather than controlled centrally, with success depending on persistence through the inevitable J-curve of initial productivity drops. The conversation reveals how a large multinational navigates the practical realities of AI deployment - from managing regulatory complexity across different geographies to making pragmatic build-versus-buy decisions - while maintaining focus on the fundamental principle that AI should augment human expertise rather than replace human judgment and responsibility.</p><p> </p><p>(0:00) Intro<br />(0:29) How AI is Used at Merck<br />(2:18) AI Applications Across the Value Chain<br />(4:31) Challenges and Risks of AI Implementation<br />(5:35) Federated Approach to AI Prioritization<br />(6:44) Future AI Use Cases and Data Challenges<br />(10:38) Building and Partnering for AI Solutions<br />(15:11) AI in Drug Discovery and R&D<br />(26:47) Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="31443587" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/7903f3bf-85f2-4c83-82ba-216af4faf394/audio/8bc7c172-d31e-47ba-b486-57804369b958/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 62: Merck KGaA Chief Data and AI Officer on Scaling AI in Pharma and The Future of Enterprise Software</itunes:title>
      <itunes:author>Walid Mehanna, Jacob Effron</itunes:author>
      <itunes:duration>00:32:45</itunes:duration>
      <itunes:summary>This episode captures Walid Mehanna&apos;s perspective on how Merck KGaA has approached enterprise AI adoption through a federated strategy that prioritizes people over technology. The core message is that successful AI implementation requires building organizational capability across three dimensions - people, processes, and technology - rather than seeking a single transformative solution. Walid argues that companies must establish a broad foundation of AI literacy (exemplified by their internal MyGPT tool reaching 25,000 users) before pursuing specialized applications, while maintaining human accountability to prevent complacency. He emphasizes that AI works best when it&apos;s treated as an experimental, iterative capability distributed across the organization rather than controlled centrally, with success depending on persistence through the inevitable J-curve of initial productivity drops. The conversation reveals how a large multinational navigates the practical realities of AI deployment - from managing regulatory complexity across different geographies to making pragmatic build-versus-buy decisions - while maintaining focus on the fundamental principle that AI should augment human expertise rather than replace human judgment and responsibility.</itunes:summary>
      <itunes:subtitle>This episode captures Walid Mehanna&apos;s perspective on how Merck KGaA has approached enterprise AI adoption through a federated strategy that prioritizes people over technology. The core message is that successful AI implementation requires building organizational capability across three dimensions - people, processes, and technology - rather than seeking a single transformative solution. Walid argues that companies must establish a broad foundation of AI literacy (exemplified by their internal MyGPT tool reaching 25,000 users) before pursuing specialized applications, while maintaining human accountability to prevent complacency. He emphasizes that AI works best when it&apos;s treated as an experimental, iterative capability distributed across the organization rather than controlled centrally, with success depending on persistence through the inevitable J-curve of initial productivity drops. The conversation reveals how a large multinational navigates the practical realities of AI deployment - from managing regulatory complexity across different geographies to making pragmatic build-versus-buy decisions - while maintaining focus on the fundamental principle that AI should augment human expertise rather than replace human judgment and responsibility.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>62</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e1d3bd77-8da7-4771-8a29-ea200a62c945</guid>
      <title>Ep 61: Co-Founder of Chai Discovery Joshua Meier on 99% Faster Drug Discovery, BioTech’s AlphaGo Moment, Building Photoshop for Molecules</title>
      <description><![CDATA[<p>In this episode, Jacob sits down with Joshua Meier, co-founder of Chai Discovery and former Chief AI Officer at Absci, to explore the breakthrough moment happening in AI drug discovery. They discuss how the field has evolved through three distinct waves, with the current generation of companies finally achieving success rates that seemed impossible just years ago. </p><p> </p><p>The conversation covers everything from moving drug discovery out of the lab and into computers, to why AI models think differently than human chemists, to the strategic decisions around open sourcing foundational models while keeping design capabilities proprietary. It's an in-depth look at how AI is fundamentally changing pharmaceutical innovation and what it means for the future of medicine.</p><p> </p><p>Check out the full Chai-2 Zero-Shot Antibody report linked here: https://www.biorxiv.org/content/10.1101/2025.07.05.663018v1.full.pdf</p><p> </p><p>(0:00) Intro<br />(1:25) The Evolution of AI in Drug Discovery<br />(5:14) Current State and Future of AI in Biotech<br />(10:08) Challenges and Modalities in Therapeutics<br />(14:44) Data Generation and Model Training<br />(22:52) Open Source and Model Development at Chai<br />(29:52) Open Source Models and Their Impact<br />(34:36) How Should Chai-2 Be Used?<br />(38:53) The Future of AI in Pharma and Biotech<br />(42:46) Key Milestones and Metrics in AI-Driven Drug Discovery<br />(47:20) Critiques and Hesitation<br />(54:01) Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Mon, 22 Sep 2025 13:17:23 +0000</pubDate>
      <author>jeffron@redpoint.com (Joshua Meier, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-61-co-founder-of-chai-discovery-joshua-meier-on-99-faster-drug-discovery-biotechs-alphago-moment-building-photoshop-for-molecules-P266_TvZ</link>
      <content:encoded><![CDATA[<p>In this episode, Jacob sits down with Joshua Meier, co-founder of Chai Discovery and former Chief AI Officer at Absci, to explore the breakthrough moment happening in AI drug discovery. They discuss how the field has evolved through three distinct waves, with the current generation of companies finally achieving success rates that seemed impossible just years ago. </p><p> </p><p>The conversation covers everything from moving drug discovery out of the lab and into computers, to why AI models think differently than human chemists, to the strategic decisions around open sourcing foundational models while keeping design capabilities proprietary. It's an in-depth look at how AI is fundamentally changing pharmaceutical innovation and what it means for the future of medicine.</p><p> </p><p>Check out the full Chai-2 Zero-Shot Antibody report linked here: https://www.biorxiv.org/content/10.1101/2025.07.05.663018v1.full.pdf</p><p> </p><p>(0:00) Intro<br />(1:25) The Evolution of AI in Drug Discovery<br />(5:14) Current State and Future of AI in Biotech<br />(10:08) Challenges and Modalities in Therapeutics<br />(14:44) Data Generation and Model Training<br />(22:52) Open Source and Model Development at Chai<br />(29:52) Open Source Models and Their Impact<br />(34:36) How Should Chai-2 Be Used?<br />(38:53) The Future of AI in Pharma and Biotech<br />(42:46) Key Milestones and Metrics in AI-Driven Drug Discovery<br />(47:20) Critiques and Hesitation<br />(54:01) Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="54481440" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/b400eee8-32e8-482b-934d-8f13680a301d/audio/821bd939-57c3-4ffe-85c9-e259ab321170/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 61: Co-Founder of Chai Discovery Joshua Meier on 99% Faster Drug Discovery, BioTech’s AlphaGo Moment, Building Photoshop for Molecules</itunes:title>
      <itunes:author>Joshua Meier, Jacob Effron</itunes:author>
      <itunes:duration>00:56:45</itunes:duration>
      <itunes:summary>In this episode, Jacob sits down with Joshua Meier, co-founder of Chai Discovery and former Chief AI Officer at Absci, to explore the breakthrough moment happening in AI drug discovery. They discuss how the field has evolved through three distinct waves, with the current generation of companies finally achieving success rates that seemed impossible just years ago. </itunes:summary>
      <itunes:subtitle>In this episode, Jacob sits down with Joshua Meier, co-founder of Chai Discovery and former Chief AI Officer at Absci, to explore the breakthrough moment happening in AI drug discovery. They discuss how the field has evolved through three distinct waves, with the current generation of companies finally achieving success rates that seemed impossible just years ago. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>61</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e15d319d-24e4-4521-a8c3-05bfa7497ede</guid>
      <title>Ep 60: General Medicine&apos;s Elliot Cohen on Lessons from PillPack and Amazon and The Future of AI x Healthcare</title>
      <description><![CDATA[<p>Elliot Cohen—PillPack co-founder and now co-founder of General Medicine—joins Jacob Effron and Nikhil (Out-of-Pocket) to unpack what “best care” really means in 2025. He explains why General Medicine is building a broad front door to care. Elliot also revisits the PillPack vs. PBMs saga, what Amazon Pharmacy got right (and what was unexpectedly hard), and how AI is already raising the bar in intake, clinical prep, and follow-up.</p><p> </p><p>(0:00) Intro<br />(0:58) Simplifying Healthcare with General Medicine<br />(1:53) The Importance of Triage in Healthcare<br />(3:22) Consumer Empowerment in Healthcare<br />(5:10) Patient Experience and Structured Forms<br />(6:27) Challenges in Healthcare Pricing Transparency<br />(8:28) Diverse Patient Needs and Quality of Care<br />(10:00) The Philosophy Behind General Medicine<br />(16:43) Consumer Directed Care: Pros and Cons<br />(18:57) PillPack<br />(35:53) Debating Insulin Search Results<br />(38:16) AI in Healthcare: A New Era<br />(39:15) Integrating AI with Clinical Teams<br />(41:39) Challenges and Opportunities in Digital Therapeutics<br />(58:21) Building a Healthcare Company: Lessons from Amazon<br />(1:01:25) Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Thu, 31 Jul 2025 13:00:17 +0000</pubDate>
      <author>jeffron@redpoint.com (Elliot Cohen, Nikhil Krishnan, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-60-general-medicines-elliot-cohen-on-lessons-from-pillpack-and-amazon-and-the-future-of-ai-x-healthcare-YubyV_wW</link>
      <content:encoded><![CDATA[<p>Elliot Cohen—PillPack co-founder and now co-founder of General Medicine—joins Jacob Effron and Nikhil (Out-of-Pocket) to unpack what “best care” really means in 2025. He explains why General Medicine is building a broad front door to care. Elliot also revisits the PillPack vs. PBMs saga, what Amazon Pharmacy got right (and what was unexpectedly hard), and how AI is already raising the bar in intake, clinical prep, and follow-up.</p><p> </p><p>(0:00) Intro<br />(0:58) Simplifying Healthcare with General Medicine<br />(1:53) The Importance of Triage in Healthcare<br />(3:22) Consumer Empowerment in Healthcare<br />(5:10) Patient Experience and Structured Forms<br />(6:27) Challenges in Healthcare Pricing Transparency<br />(8:28) Diverse Patient Needs and Quality of Care<br />(10:00) The Philosophy Behind General Medicine<br />(16:43) Consumer Directed Care: Pros and Cons<br />(18:57) PillPack<br />(35:53) Debating Insulin Search Results<br />(38:16) AI in Healthcare: A New Era<br />(39:15) Integrating AI with Clinical Teams<br />(41:39) Challenges and Opportunities in Digital Therapeutics<br />(58:21) Building a Healthcare Company: Lessons from Amazon<br />(1:01:25) Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="64859043" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/5d482a5b-f38c-4637-aedd-99b905443313/audio/08d4ce50-51b1-4361-a7bf-6a522ee92d84/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 60: General Medicine&apos;s Elliot Cohen on Lessons from PillPack and Amazon and The Future of AI x Healthcare</itunes:title>
      <itunes:author>Elliot Cohen, Nikhil Krishnan, Jacob Effron</itunes:author>
      <itunes:duration>01:07:33</itunes:duration>
      <itunes:summary>Elliot Cohen—PillPack co-founder and now co-founder of General Medicine—joins Jacob Effron and Nikhil (Out-of-Pocket) to unpack what “best care” really means in 2025. He explains why General Medicine is building a broad front door to care. Elliot also revisits the PillPack vs. PBMs saga, what Amazon Pharmacy got right (and what was unexpectedly hard), and how AI is already raising the bar in intake, clinical prep, and follow-up.</itunes:summary>
      <itunes:subtitle>Elliot Cohen—PillPack co-founder and now co-founder of General Medicine—joins Jacob Effron and Nikhil (Out-of-Pocket) to unpack what “best care” really means in 2025. He explains why General Medicine is building a broad front door to care. Elliot also revisits the PillPack vs. PBMs saga, what Amazon Pharmacy got right (and what was unexpectedly hard), and how AI is already raising the bar in intake, clinical prep, and follow-up.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>60</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6940ac89-f545-417a-bd24-01a8d787b4d1</guid>
      <title>Flashback: Hinge Health CEO Daniel Perez on Effective Employer Sales, Patient Engagement and His Top Advice to Founders</title>
      <description><![CDATA[<p>Flashback episode in honor of Hinge Health's IPO this week. In the episode, Jacob and Nikhil sit down with Daniel Perez, the Co-Founder and CEO of Hinge Health, a digital clinic for patients with joint and muscle pain. They discuss Hinge Health’s strategy for selling to employers, how digital health solutions can reach and retain users, the role of software x hardware in disrupting healthcare, and more.</p><p> </p><p>(0:00) Intro<br />(2:34) The Evolution of Employer Health Solutions<br />(4:03) Challenges and Strategies in Digital Health<br />(7:07) Focus on Musculoskeletal Care<br />(9:51) Engaging and Retaining Patients<br />(16:17) Marketing and Awareness Strategies<br />(19:31) The Role of Independent Validators<br />(22:27) Clinical Validation and R&D Excellence<br />(23:04) Healthy Competition and Market Differentiation<br />(23:59) Product Superiority and Customer Validation<br />(26:05) Team Dynamics and Tough Decisions<br />(29:49) Future of Hinge Health and Healthcare Automation<br />(31:44) AI and Technology Integration<br />(36:18) Hardware Innovations and Market Impact<br />(39:19) Value-Based Care and Outcome Guarantees<br />(41:14) Regulatory Challenges and Innovation Constraints<br />(43:38) Closing Thoughts and Entrepreneurial Advice</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Fri, 23 May 2025 20:16:23 +0000</pubDate>
      <author>jeffron@redpoint.com (Daniel Perez, Jacob Effron, Nikhil Krishnan)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/flashback-hinge-health-ceo-daniel-perez-on-effective-employer-sales-patient-engagement-and-his-top-advice-to-founders-_Z1kjxWI</link>
      <content:encoded><![CDATA[<p>Flashback episode in honor of Hinge Health's IPO this week. In the episode, Jacob and Nikhil sit down with Daniel Perez, the Co-Founder and CEO of Hinge Health, a digital clinic for patients with joint and muscle pain. They discuss Hinge Health’s strategy for selling to employers, how digital health solutions can reach and retain users, the role of software x hardware in disrupting healthcare, and more.</p><p> </p><p>(0:00) Intro<br />(2:34) The Evolution of Employer Health Solutions<br />(4:03) Challenges and Strategies in Digital Health<br />(7:07) Focus on Musculoskeletal Care<br />(9:51) Engaging and Retaining Patients<br />(16:17) Marketing and Awareness Strategies<br />(19:31) The Role of Independent Validators<br />(22:27) Clinical Validation and R&D Excellence<br />(23:04) Healthy Competition and Market Differentiation<br />(23:59) Product Superiority and Customer Validation<br />(26:05) Team Dynamics and Tough Decisions<br />(29:49) Future of Hinge Health and Healthcare Automation<br />(31:44) AI and Technology Integration<br />(36:18) Hardware Innovations and Market Impact<br />(39:19) Value-Based Care and Outcome Guarantees<br />(41:14) Regulatory Challenges and Innovation Constraints<br />(43:38) Closing Thoughts and Entrepreneurial Advice</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="43545538" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/c77bc6be-b625-4a64-a881-2c43da19c5be/audio/5de7a65d-c6a0-45e8-9c6d-8e44684b23e2/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Flashback: Hinge Health CEO Daniel Perez on Effective Employer Sales, Patient Engagement and His Top Advice to Founders</itunes:title>
      <itunes:author>Daniel Perez, Jacob Effron, Nikhil Krishnan</itunes:author>
      <itunes:duration>00:45:21</itunes:duration>
      <itunes:summary>Flashback episode in honor of Hinge Health&apos;s IPO this week. In the episode, Jacob and Nikhil sit down with Daniel Perez, the Co-Founder and CEO of Hinge Health, a digital clinic for patients with joint and muscle pain. They discuss Hinge Health’s strategy for selling to employers, how digital health solutions can reach and retain users, the role of software x hardware in disrupting healthcare, and more.</itunes:summary>
      <itunes:subtitle>Flashback episode in honor of Hinge Health&apos;s IPO this week. In the episode, Jacob and Nikhil sit down with Daniel Perez, the Co-Founder and CEO of Hinge Health, a digital clinic for patients with joint and muscle pain. They discuss Hinge Health’s strategy for selling to employers, how digital health solutions can reach and retain users, the role of software x hardware in disrupting healthcare, and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>bonus</itunes:episodeType>
    </item>
    <item>
      <guid isPermaLink="false">ee85c4bc-4ae2-4feb-a1f0-fd332971af2a</guid>
      <title>Ep 59: Photon Health CEO Otto Sipe on the Future of Pharmacies, PBMs and GLP-1s</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Otto Sipe. Otto is the CEO and Co-Founder of Photon Health, which enables patients to select their own pharmacies with price and inventory transparency. The company has raised over $16 million from investors including Flare Capital Partners and Notation Capital. They discuss where pharmacies and PBMs are headed, the evolution of E-Prescribing, the impact of GLP-1s & AI, and more.</p><p> </p><p>(0:00) Intro<br />(0:51) History and Evolution of E-Prescribing<br />(3:02) Challenges in Current E-Prescribing Systems<br />(6:28) Photon Health's Innovative Approach<br />(8:17) Patient and Provider Behavior Changes<br />(11:21) Pharmacy Industry Landscape and Future<br />(13:43) Interactions with PBMs and Market Dynamics<br />(16:48) Future of PBMs and Drug Pricing<br />(20:38) Quality and Marketplace Experience in Pharmacies<br />(23:30) Advising Independent Pharmacies for Future Success<br />(24:24) Challenges and Strategies in Retail Pharmacy<br />(25:45) Pharmacy Economics and Supply Chain Issues<br />(30:21) The Role and Potential of Pharmacists<br />(36:01) AI in Pharmacy: Photon’s Approach<br />(38:28) Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Thu, 1 May 2025 13:00:09 +0000</pubDate>
      <author>jeffron@redpoint.com (Otto Sipe, Nikhil Krishnan, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-59-photon-health-ceo-otto-sipe-on-the-future-of-pharmacies-pbms-and-glp-1s-2zBX2R1D</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Otto Sipe. Otto is the CEO and Co-Founder of Photon Health, which enables patients to select their own pharmacies with price and inventory transparency. The company has raised over $16 million from investors including Flare Capital Partners and Notation Capital. They discuss where pharmacies and PBMs are headed, the evolution of E-Prescribing, the impact of GLP-1s & AI, and more.</p><p> </p><p>(0:00) Intro<br />(0:51) History and Evolution of E-Prescribing<br />(3:02) Challenges in Current E-Prescribing Systems<br />(6:28) Photon Health's Innovative Approach<br />(8:17) Patient and Provider Behavior Changes<br />(11:21) Pharmacy Industry Landscape and Future<br />(13:43) Interactions with PBMs and Market Dynamics<br />(16:48) Future of PBMs and Drug Pricing<br />(20:38) Quality and Marketplace Experience in Pharmacies<br />(23:30) Advising Independent Pharmacies for Future Success<br />(24:24) Challenges and Strategies in Retail Pharmacy<br />(25:45) Pharmacy Economics and Supply Chain Issues<br />(30:21) The Role and Potential of Pharmacists<br />(36:01) AI in Pharmacy: Photon’s Approach<br />(38:28) Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="43922955" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/c968459d-c29f-4130-87e4-f0774fd17a59/audio/9cf1a5c7-2b5f-44a3-80c7-736cc58b0be1/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 59: Photon Health CEO Otto Sipe on the Future of Pharmacies, PBMs and GLP-1s</itunes:title>
      <itunes:author>Otto Sipe, Nikhil Krishnan, Jacob Effron</itunes:author>
      <itunes:duration>00:45:45</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Otto Sipe. Otto is the CEO and Co-Founder of Photon Health, which enables patients to select their own pharmacies with price and inventory transparency. The company has raised over $16 million from investors including Flare Capital Partners and Notation Capital. They discuss where pharmacies and PBMs are headed, the evolution of E-Prescribing, the impact of GLP-1s &amp; AI, and more.</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Otto Sipe. Otto is the CEO and Co-Founder of Photon Health, which enables patients to select their own pharmacies with price and inventory transparency. The company has raised over $16 million from investors including Flare Capital Partners and Notation Capital. They discuss where pharmacies and PBMs are headed, the evolution of E-Prescribing, the impact of GLP-1s &amp; AI, and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>59</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">cc321dde-a4e5-43fc-9668-9163116e7621</guid>
      <title>Ep 58: Iora Health Former CEO Rushika Fernandopulle on Current State of Value Based Care Across Payer Types and AI’s Role in Primary Care</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Dr. Rushika Fernandopulle. Rushika is the former CEO and Co-Founder of Iora Health, a primary care provider centered around value-based care and Medicare that One Medical acquired for $2.1 billion. They discuss why we’re still in the second inning of value-based care, intersections of tech and healthcare, what it takes for VBC to succeed, and more.</p><p> </p><p>[0:00] Intro<br />[0:29] Early Days of Value-Based Care<br />[2:34] Challenges in Commercial Value-Based Care<br />[5:20] Adapting Care Models for Different Populations<br />[13:08] Medicaid and Long-Term Care Issues<br />[16:30] Big Tech's Foray into Healthcare<br />[20:37] Amazon's Healthcare Strategy<br />[21:09] Challenges in Serving Low-Income Seniors<br />[21:43] Innovative Solutions for Patient Transportation<br />[22:16] The Economics of Healthcare Visits<br />[23:22] Building a Custom EHR System<br />[27:34] The Role of AI in Modern Healthcare<br />[33:17] Future of Primary Care and Policy Implications</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Thu, 10 Apr 2025 13:00:35 +0000</pubDate>
      <author>jeffron@redpoint.com (Rushika Fernandopulle, Nikhil Krishnan, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-58-iora-health-former-ceo-rushika-fernandopulle-on-current-state-of-value-based-care-across-payer-types-and-ais-role-in-primary-care-krCj5abo</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Dr. Rushika Fernandopulle. Rushika is the former CEO and Co-Founder of Iora Health, a primary care provider centered around value-based care and Medicare that One Medical acquired for $2.1 billion. They discuss why we’re still in the second inning of value-based care, intersections of tech and healthcare, what it takes for VBC to succeed, and more.</p><p> </p><p>[0:00] Intro<br />[0:29] Early Days of Value-Based Care<br />[2:34] Challenges in Commercial Value-Based Care<br />[5:20] Adapting Care Models for Different Populations<br />[13:08] Medicaid and Long-Term Care Issues<br />[16:30] Big Tech's Foray into Healthcare<br />[20:37] Amazon's Healthcare Strategy<br />[21:09] Challenges in Serving Low-Income Seniors<br />[21:43] Innovative Solutions for Patient Transportation<br />[22:16] The Economics of Healthcare Visits<br />[23:22] Building a Custom EHR System<br />[27:34] The Role of AI in Modern Healthcare<br />[33:17] Future of Primary Care and Policy Implications</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="37514805" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/070e5522-da90-403d-9dc0-f15619d620e5/audio/158ba53f-6f74-4066-8851-134fb6807d97/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 58: Iora Health Former CEO Rushika Fernandopulle on Current State of Value Based Care Across Payer Types and AI’s Role in Primary Care</itunes:title>
      <itunes:author>Rushika Fernandopulle, Nikhil Krishnan, Jacob Effron</itunes:author>
      <itunes:duration>00:39:04</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Dr. Rushika Fernandopulle. Rushika is the former CEO and Co-Founder of Iora Health, a primary care provider centered around value-based care and Medicare that was acquired by One Medical for $2.1 billion. They discuss why we’re still in the second inning of value-based care, intersections of tech and healthcare, what it takes for VBC to succeed, and more. </itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Dr. Rushika Fernandopulle. Rushika is the former CEO and Co-Founder of Iora Health, a primary care provider centered around value-based care and Medicare that was acquired by One Medical for $2.1 billion. They discuss why we’re still in the second inning of value-based care, intersections of tech and healthcare, what it takes for VBC to succeed, and more. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>58</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ee0e9fd7-05dc-493b-869f-d8bfc97aeaec</guid>
      <title>Ep 57: Taro Health CEO Frank Wu on Direct Primary Care, The History of InsurTech and AI for Payers</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Frank Wu, the Co-Founder and CEO of Taro Health. Taro Health is a health insurance plan currently live in Maine and Oklahoma that offers unlimited primary care and mental health visits. The company has raised over $18m from investors like Hummingbird Ventures, Quiet Capital, and FPV Ventures. They discuss creating value in InsurTech, building a health plan for Direct Primary Care providers, what’s next for health insurance, and more.</p><p> </p><p>[0:00] Intro<br />[0:18] Frank’s Background and Journey<br />[1:17] Introduction to Taro Health<br />[2:50] Challenges and Strategies in Health Insurance<br />[7:24] Direct Primary Care Model<br />[13:01] Patient and Doctor Archetypes in DPC<br />[17:01] Enrollment and Market Strategies<br />[28:56] Generative AI in Health Insurance<br />[35:31] Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Fri, 14 Mar 2025 13:00:04 +0000</pubDate>
      <author>jeffron@redpoint.com (Frank Wu, Jacob Effron, Nikhil Krishnan)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-57-taro-health-ceo-frank-wu-on-direct-primary-care-the-history-of-insurtech-and-ai-for-payers-l9wR3R29</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Frank Wu, the Co-Founder and CEO of Taro Health. Taro Health is a health insurance plan currently live in Maine and Oklahoma that offers unlimited primary care and mental health visits. The company has raised over $18m from investors like Hummingbird Ventures, Quiet Capital, and FPV Ventures. They discuss creating value in InsurTech, building a health plan for Direct Primary Care providers, what’s next for health insurance, and more.</p><p> </p><p>[0:00] Intro<br />[0:18] Frank’s Background and Journey<br />[1:17] Introduction to Taro Health<br />[2:50] Challenges and Strategies in Health Insurance<br />[7:24] Direct Primary Care Model<br />[13:01] Patient and Doctor Archetypes in DPC<br />[17:01] Enrollment and Market Strategies<br />[28:56] Generative AI in Health Insurance<br />[35:31] Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="40357345" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/19e3014a-8dcc-4c94-b884-c29fc41df7f5/audio/e4e631c2-dbc3-4b39-af76-4e77747e73ef/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 57: Taro Health CEO Frank Wu on Direct Primary Care, The History of InsurTech and AI for Payers</itunes:title>
      <itunes:author>Frank Wu, Jacob Effron, Nikhil Krishnan</itunes:author>
      <itunes:duration>00:42:02</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Frank Wu, the Co-Founder and CEO of Taro Health. Taro Health is a health insurance plan currently live in Maine and Oklahoma that offers unlimited primary care and mental health visits. The company has raised over $18m from investors like Hummingbird Ventures, Quiet Capital, and FPV Ventures. They discuss creating value in InsurTech, building a health plan for Direct Primary Care providers, what’s next for health insurance, and more.</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Frank Wu, the Co-Founder and CEO of Taro Health. Taro Health is a health insurance plan currently live in Maine and Oklahoma that offers unlimited primary care and mental health visits. The company has raised over $18m from investors like Hummingbird Ventures, Quiet Capital, and FPV Ventures. They discuss creating value in InsurTech, building a health plan for Direct Primary Care providers, what’s next for health insurance, and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>57</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">7eb537a4-d20d-4593-8527-30d709a3b044</guid>
      <title>Ep 56: Providence CEO Erik Wexler on Evaluating Partnerships, Policy and Leadership</title>
      <description><![CDATA[<p>Jacob sits down with Erik Wexler, the President and CEO of Providence. Providence is a non-profit, faith-based health system with 51 hospitals and 1,000 clinics across seven states. They discuss how to think about new AI opportunities with discipline, the value of health system partnerships, programs to support health equity, and more.</p><p>[0:00] Intro<br />[2:07] Challenges and Opportunities with AI<br />[3:38] Leadership and Organizational Focus<br />[5:30] Whole Person Care and Health Equity<br />[7:23] Financial Challenges in Healthcare<br />[9:25] Collaborations and Partnerships<br />[13:38] Innovations in Healthcare Delivery<br />[15:12] Tech Integration in Healthcare<br />[16:55] Choosing the Right Innovations<br />[17:48] Policy Landscape and Concerns<br />[19:33] Handling Wildfires and Crisis Management<br />[21:59] Commitment to Climate Change and Sustainability<br />[24:14] Health Equity and Community Investment<br />[27:14] Challenges and Successes in Healthcare Innovation<br />[29:18] Future of Healthcare and Final Thoughts</p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Tue, 25 Feb 2025 14:01:02 +0000</pubDate>
      <author>jeffron@redpoint.com (Erik Wexler, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-56-providence-ceo-erik-wexler-on-evaluating-partnerships-policy-and-leadership-YXai2EzR</link>
      <content:encoded><![CDATA[<p>Jacob sits down with Erik Wexler, the President and CEO of Providence. Providence is a non-profit, faith-based health system with 51 hospitals and 1,000 clinics across seven states. They discuss how to think about new AI opportunities with discipline, the value of health system partnerships, programs to support health equity, and more.</p><p>[0:00] Intro<br />[2:07] Challenges and Opportunities with AI<br />[3:38] Leadership and Organizational Focus<br />[5:30] Whole Person Care and Health Equity<br />[7:23] Financial Challenges in Healthcare<br />[9:25] Collaborations and Partnerships<br />[13:38] Innovations in Healthcare Delivery<br />[15:12] Tech Integration in Healthcare<br />[16:55] Choosing the Right Innovations<br />[17:48] Policy Landscape and Concerns<br />[19:33] Handling Wildfires and Crisis Management<br />[21:59] Commitment to Climate Change and Sustainability<br />[24:14] Health Equity and Community Investment<br />[27:14] Challenges and Successes in Healthcare Innovation<br />[29:18] Future of Healthcare and Final Thoughts</p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="33683373" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/3efee463-9ae6-4e1e-b261-8ab7ddb992eb/audio/13383bf5-4be4-4f19-b29f-d7720fdfc67a/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 56: Providence CEO Erik Wexler on Evaluating Partnerships, Policy and Leadership</itunes:title>
      <itunes:author>Erik Wexler, Jacob Effron</itunes:author>
      <itunes:duration>00:35:05</itunes:duration>
      <itunes:summary>Jacob sits down with Erik Wexler, the President and CEO of Providence. Providence is a non-profit, faith-based health system with 51 hospitals and 1,000 clinics across seven states. They discuss how to think about new AI opportunities with discipline, the value of health system partnerships, programs to support health equity, and more. </itunes:summary>
      <itunes:subtitle>Jacob sits down with Erik Wexler, the President and CEO of Providence. Providence is a non-profit, faith-based health system with 51 hospitals and 1,000 clinics across seven states. They discuss how to think about new AI opportunities with discipline, the value of health system partnerships, programs to support health equity, and more. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>56</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">8d641b9e-f0da-452b-8fe6-b1ef6eb4a738</guid>
      <title>Ep 55: Hinge Health CEO Daniel Perez on Effective Employer Sales, Patient Engagement and His Top Advice to Founders</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Daniel Perez, the Co-Founder and CEO of Hinge Health. Hinge Health is a digital clinic for patients with joint and muscle pain, having raised $800M+ from investors like Coatue and Tiger Global. They discuss Hinge Health’s strategy for selling to employers, how digital health solutions can reach and retain users, the role of software x hardware in disrupting healthcare, and more.</p><p> </p><p>[0:00] Intro<br />[2:34] The Evolution of Employer Health Solutions<br />[4:03] Challenges and Strategies in Digital Health<br />[7:07] Focus on Musculoskeletal Care<br />[9:51] Engaging and Retaining Patients<br />[16:17] Marketing and Awareness Strategies<br />[19:31] The Role of Independent Validators<br />[22:27] Clinical Validation and R&D Excellence<br />[23:04] Healthy Competition and Market Differentiation<br />[23:59] Product Superiority and Customer Validation<br />[26:05] Team Dynamics and Tough Decisions<br />[29:49] Future of Hinge Health and Healthcare Automation<br />[31:44] AI and Technology Integration<br />[36:18] Hardware Innovations and Market Impact<br />[39:19] Value-Based Care and Outcome Guarantees<br />[41:14] Regulatory Challenges and Innovation Constraints<br />[43:38] Closing Thoughts and Entrepreneurial Advice</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Tue, 11 Feb 2025 14:00:27 +0000</pubDate>
      <author>jeffron@redpoint.com (Daniel Perez, Jacob Effron, Nikhil Krishnan)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-55-hinge-health-ceo-daniel-perez-on-effective-employer-sales-patient-engagement-and-his-top-advice-to-founders-0GdQYr07</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Daniel Perez, the Co-Founder and CEO of Hinge Health. Hinge Health is a digital clinic for patients with joint and muscle pain, having raised $800M+ from investors like Coatue and Tiger Global. They discuss Hinge Health’s strategy for selling to employers, how digital health solutions can reach and retain users, the role of software x hardware in disrupting healthcare, and more.</p><p> </p><p>[0:00] Intro<br />[2:34] The Evolution of Employer Health Solutions<br />[4:03] Challenges and Strategies in Digital Health<br />[7:07] Focus on Musculoskeletal Care<br />[9:51] Engaging and Retaining Patients<br />[16:17] Marketing and Awareness Strategies<br />[19:31] The Role of Independent Validators<br />[22:27] Clinical Validation and R&D Excellence<br />[23:04] Healthy Competition and Market Differentiation<br />[23:59] Product Superiority and Customer Validation<br />[26:05] Team Dynamics and Tough Decisions<br />[29:49] Future of Hinge Health and Healthcare Automation<br />[31:44] AI and Technology Integration<br />[36:18] Hardware Innovations and Market Impact<br />[39:19] Value-Based Care and Outcome Guarantees<br />[41:14] Regulatory Challenges and Innovation Constraints<br />[43:38] Closing Thoughts and Entrepreneurial Advice</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="43545538" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/031f8c97-313f-4dd4-b846-466c3a62daf6/audio/db596207-d26f-4760-8003-8e8e07a366f3/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 55: Hinge Health CEO Daniel Perez on Effective Employer Sales, Patient Engagement and His Top Advice to Founders</itunes:title>
      <itunes:author>Daniel Perez, Jacob Effron, Nikhil Krishnan</itunes:author>
      <itunes:duration>00:45:21</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Daniel Perez, the Co-Founder and CEO of Hinge Health. Hinge Health is a digital clinic for patients with joint and muscle pain, having raised $800M+ from investors like Coatue and Tiger Global. They discuss Hinge Health’s strategy for selling to employers, how digital health solutions can reach and retain users, the role of software x hardware in disrupting healthcare, and more. </itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Daniel Perez, the Co-Founder and CEO of Hinge Health. Hinge Health is a digital clinic for patients with joint and muscle pain, having raised $800M+ from investors like Coatue and Tiger Global. They discuss Hinge Health’s strategy for selling to employers, how digital health solutions can reach and retain users, the role of software x hardware in disrupting healthcare, and more. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>55</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">516e5e17-e305-49c8-9cff-300f7b4ef230</guid>
      <title>Ep 54: General Catalyst CEO Hemant Taneja on Buying a Health System, $100B Healthcare Companies and The Future of AI and Venture</title>
      <description><![CDATA[<p>Jacob sits down with Hemant Taneja, the CEO & Managing Director of General Catalyst. GC is one of the world’s largest venture capital firms, most recently raising an $8B fund in 2024. The firm has invested in companies like Livongo, Cityblock Health, and Hippocratic AI. They discuss the possibility of a $100B healthcare company, how buying a health system can accelerate partnerships, what will succeed in AI, and more.</p><p> </p><p>[0:00] Intro<br />[0:54] Hemant’s Healthcare Journey<br />[2:25] A Vision for 2030<br />[3:36] Transforming Healthcare Systems<br />[6:03] The Role of AI and Technology in Healthcare<br />[9:04] Incubation and Investment Strategies<br />[13:43] Platform Focus in Health Tech<br />[21:42] Exploring International Healthcare Opportunities<br />[24:48] AI Transformations Across Industries<br />[25:51] Innovative Financing in Venture Capital<br />[34:41] The Future of AI and Venture Capital<br />[38:18] Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Tue, 28 Jan 2025 13:59:10 +0000</pubDate>
      <author>jeffron@redpoint.com (Hemant Taneja, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-54-general-catalyst-ceo-hemant-taneja-on-buying-a-health-system-100b-healthcare-companies-and-the-future-of-ai-and-venturec-wicM8Sci</link>
      <content:encoded><![CDATA[<p>Jacob sits down with Hemant Taneja, the CEO & Managing Director of General Catalyst. GC is one of the world’s largest venture capital firms, most recently raising an $8B fund in 2024. The firm has invested in companies like Livongo, Cityblock Health, and Hippocratic AI. They discuss the possibility of a $100B healthcare company, how buying a health system can accelerate partnerships, what will succeed in AI, and more.</p><p> </p><p>[0:00] Intro<br />[0:54] Hemant’s Healthcare Journey<br />[2:25] A Vision for 2030<br />[3:36] Transforming Healthcare Systems<br />[6:03] The Role of AI and Technology in Healthcare<br />[9:04] Incubation and Investment Strategies<br />[13:43] Platform Focus in Health Tech<br />[21:42] Exploring International Healthcare Opportunities<br />[24:48] AI Transformations Across Industries<br />[25:51] Innovative Financing in Venture Capital<br />[34:41] The Future of AI and Venture Capital<br />[38:18] Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="41110926" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/c927f423-696e-4050-9640-8dba60b431ee/audio/d524b156-8e8a-47b1-8284-244e1ef563e3/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 54: General Catalyst CEO Hemant Taneja on Buying a Health System, $100B Healthcare Companies and The Future of AI and Venture</itunes:title>
      <itunes:author>Hemant Taneja, Jacob Effron</itunes:author>
      <itunes:duration>00:42:49</itunes:duration>
      <itunes:summary>Jacob sits down with Hemant Taneja, the CEO &amp; Managing Director of General Catalyst. GC is one of the world’s largest venture capital firms, most recently raising an $8B fund in 2024. The firm has invested in companies like Livongo, Cityblock Health, and Hippocratic AI. They discuss the possibility of a $100B healthcare company, how buying a health system can accelerate partnerships, what will succeed in AI, and more.</itunes:summary>
      <itunes:subtitle>Jacob sits down with Hemant Taneja, the CEO &amp; Managing Director of General Catalyst. GC is one of the world’s largest venture capital firms, most recently raising an $8B fund in 2024. The firm has invested in companies like Livongo, Cityblock Health, and Hippocratic AI. They discuss the possibility of a $100B healthcare company, how buying a health system can accelerate partnerships, what will succeed in AI, and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>54</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ff1c3c10-8a8d-4501-a38c-254feb614f17</guid>
      <title>Ep 53: Cradle CEO Stef van Grieken on the State of AI x Bio and Selling SaaS to Pharma</title>
      <description><![CDATA[<p>Jacob sits down with Stef van Grieken, Co-Founder & CEO of Cradle. Cradle has raised over $100M from investors like IVP and Index Ventures to build and expand their AI-enabled protein engineering platform. They discuss how Cradle plans to use their new Series B funding, what’s been happening in AI bio, the technical underpinnings of Cradle’s platform, and more.</p><p> </p><p>[0:00] Intro<br />[0:22] Cradle Bio's Rapid Growth and AI Innovations<br />[0:53] The State of AI in Drug Development<br />[1:15] Challenges and Opportunities in AI Biospace<br />[2:21] Cradle Bio's Approach to Biologics Development<br />[3:11] AI's Role in Hit Identification and Lead Optimization<br />[7:42] Cradle Bio's Software and Customer Base<br />[10:33] Inside Cradle Bio's Lab and Data Strategy<br />[24:10] Future Directions and Protein Modalities<br />[26:21] Navigating the Pharma SaaS Market<br />[28:48] Challenges in Adopting New Protocols<br />[30:15] Software vs. Service Companies<br />[31:47] Gaps in Drug Development<br />[33:46] Advances in AI and Bio<br />[41:28] Future of Drug Discovery<br />[44:18] Advice for Aspiring Bio Entrepreneurs<br />[48:03] Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Tue, 3 Dec 2024 14:00:04 +0000</pubDate>
      <author>jeffron@redpoint.com (Stef van Grieken, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-53-cradle-ceo-stef-van-grieken-on-the-state-of-ai-x-bio-and-selling-saas-to-pharma-KWvm1_jX</link>
      <content:encoded><![CDATA[<p>Jacob sits down with Stef van Grieken, Co-Founder & CEO of Cradle. Cradle has raised over $100M from investors like IVP and Index Ventures to build and expand their AI-enabled protein engineering platform. They discuss how Cradle plans to use their new Series B funding, what’s been happening in AI bio, the technical underpinnings of Cradle’s platform, and more.</p><p> </p><p>[0:00] Intro<br />[0:22] Cradle Bio's Rapid Growth and AI Innovations<br />[0:53] The State of AI in Drug Development<br />[1:15] Challenges and Opportunities in AI Biospace<br />[2:21] Cradle Bio's Approach to Biologics Development<br />[3:11] AI's Role in Hit Identification and Lead Optimization<br />[7:42] Cradle Bio's Software and Customer Base<br />[10:33] Inside Cradle Bio's Lab and Data Strategy<br />[24:10] Future Directions and Protein Modalities<br />[26:21] Navigating the Pharma SaaS Market<br />[28:48] Challenges in Adopting New Protocols<br />[30:15] Software vs. Service Companies<br />[31:47] Gaps in Drug Development<br />[33:46] Advances in AI and Bio<br />[41:28] Future of Drug Discovery<br />[44:18] Advice for Aspiring Bio Entrepreneurs<br />[48:03] Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="51006527" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/49e8d1e3-3cc9-46e0-a5d4-3a63ed2f153e/audio/bae75db2-4390-4f61-ba2b-307e1792ea62/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 53: Cradle CEO Stef van Grieken on the State of AI x Bio and Selling SaaS to Pharma</itunes:title>
      <itunes:author>Stef van Grieken, Jacob Effron</itunes:author>
      <itunes:duration>00:53:07</itunes:duration>
      <itunes:summary>Jacob sits down with Stef van Grieken, Co-Founder &amp; CEO of Cradle. Cradle has raised over $100M from investors like IVP and Index Ventures to build and expand their AI-enabled protein engineering platform. They discuss how Cradle plans to use their new Series B funding, what’s been happening in AI bio, the technical underpinnings of Cradle’s platform, and more. </itunes:summary>
      <itunes:subtitle>Jacob sits down with Stef van Grieken, Co-Founder &amp; CEO of Cradle. Cradle has raised over $100M from investors like IVP and Index Ventures to build and expand their AI-enabled protein engineering platform. They discuss how Cradle plans to use their new Series B funding, what’s been happening in AI bio, the technical underpinnings of Cradle’s platform, and more. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>53</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">0f957dff-f7f2-4b00-baee-dfa555f1f69a</guid>
      <title>Ep 52: knownwell CMO Dr. Angela Fitch on The Future of GLP-1s and New Approaches to Obesity Medicine</title>
      <description><![CDATA[<p>Jacob sits down with Dr. Angela Fitch, the Founder and CMO of knownwell. knownwell has raised $25 million from investors like a16z and Flare Capital Partners to provide weight-inclusive primary care and metabolic health care. They discuss the future of obesity care, where we are with GLP-1s, the need to expand coverage, and more.</p><p> </p><p>[0:00] Intro</p><p>[1:06] Current State of Obesity Medicine</p><p>[2:47] The knownwell Approach</p><p>[6:06] Challenges in Obesity Treatment</p><p>[7:23] The Future of Obesity Medication</p><p>[12:40] Insurance and Access Issues</p><p>[32:19] Supply Chain and Distribution</p><p>[35:38] Final Thoughts and Resources</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Thu, 14 Nov 2024 13:15:30 +0000</pubDate>
      <author>jeffron@redpoint.com (Angela Fitch, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-52-knownwell-cmo-dr-angela-fitch-on-the-future-of-glp-1s-and-new-approaches-to-obesity-medicine-0degu8uZ</link>
      <content:encoded><![CDATA[<p>Jacob sits down with Dr. Angela Fitch, the Founder and CMO of knownwell. knownwell has raised $25 million from investors like a16z and Flare Capital Partners to provide weight-inclusive primary care and metabolic health care. They discuss the future of obesity care, where we are with GLP-1s, the need to expand coverage, and more.</p><p> </p><p>[0:00] Intro</p><p>[1:06] Current State of Obesity Medicine</p><p>[2:47] The knownwell Approach</p><p>[6:06] Challenges in Obesity Treatment</p><p>[7:23] The Future of Obesity Medication</p><p>[12:40] Insurance and Access Issues</p><p>[32:19] Supply Chain and Distribution</p><p>[35:38] Final Thoughts and Resources</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="37332157" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/86f0d073-4518-4bcf-9fc7-d00efcd45ccb/audio/acb1f3c8-a09d-4f26-b3d2-c32491c2ee06/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 52: knownwell CMO Dr. Angela Fitch on The Future of GLP-1s and New Approaches to Obesity Medicine</itunes:title>
      <itunes:author>Angela Fitch, Jacob Effron</itunes:author>
      <itunes:duration>00:38:53</itunes:duration>
      <itunes:summary>Jacob sits down with Dr. Angela Fitch, the Founder and CMO of knownwell. knownwell has raised $25 million from investors like a16z and Flare Capital Partners to provide weight-inclusive primary care and metabolic health care. They discuss the future of obesity care, where we are with GLP-1s, the need to expand coverage, and more.</itunes:summary>
      <itunes:subtitle>Jacob sits down with Dr. Angela Fitch, the Founder and CMO of knownwell. knownwell has raised $25 million from investors like a16z and Flare Capital Partners to provide weight-inclusive primary care and metabolic health care. They discuss the future of obesity care, where we are with GLP-1s, the need to expand coverage, and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>52</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f357d619-7cdb-4205-8362-5384ed8250ea</guid>
      <title>Ep 51: Privia CEO Parth Mehrotra on The Future of Physician Enablement and How To Manage Risk Successfully</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Parth Mehrotra, CEO of Privia Health. Privia is a physician enablement platform partnering with 4500+ providers towards practice improvement and value-based care. They discuss the most important ways to manage risk, building effective physician enablement solutions, the future of value-based care programs & contracts, and more.</p><p> </p><p>[0:00] Intro</p><p>[0:55] Privia's Business Model and Footprint</p><p>[3:26] Physician Choices and Privia's Role</p><p>[6:06] Evolution of Value-Based Care</p><p>[8:42] Future Role of Payers in Healthcare</p><p>[10:48] Choosing Geographic Markets for Expansion</p><p>[11:53] Physician Enablement Market Dynamics</p><p>[15:02] Influencing Practice Processes Without Ownership</p><p>[18:52] Evaluating Value-Based Programs</p><p>[21:47] Capabilities Needed for Risk-Based Contracts</p><p>[24:28] Risk Pooling and Healthcare Economics</p><p>[28:31] Future of Value-Based Care</p><p>[31:40] Primary Care and Specialist Roles</p><p>[36:18] Commercial vs. Medicare Value-Based Care</p><p>[39:30] AI in Healthcare: Current and Future Applications</p><p>[43:02] Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Tue, 22 Oct 2024 13:01:07 +0000</pubDate>
      <author>jeffron@redpoint.com (Parth Mehrotra, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-51-privia-ceo-parth-mehrotra-on-the-future-of-physician-enablement-and-how-to-manage-risk-successfully-OV4Tfxqn</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Parth Mehrotra, CEO of Privia Health. Privia is a physician enablement platform partnering with 4500+ providers towards practice improvement and value-based care. They discuss the most important ways to manage risk, building effective physician enablement solutions, the future of value-based care programs & contracts, and more.</p><p> </p><p>[0:00] Intro</p><p>[0:55] Privia's Business Model and Footprint</p><p>[3:26] Physician Choices and Privia's Role</p><p>[6:06] Evolution of Value-Based Care</p><p>[8:42] Future Role of Payers in Healthcare</p><p>[10:48] Choosing Geographic Markets for Expansion</p><p>[11:53] Physician Enablement Market Dynamics</p><p>[15:02] Influencing Practice Processes Without Ownership</p><p>[18:52] Evaluating Value-Based Programs</p><p>[21:47] Capabilities Needed for Risk-Based Contracts</p><p>[24:28] Risk Pooling and Healthcare Economics</p><p>[28:31] Future of Value-Based Care</p><p>[31:40] Primary Care and Specialist Roles</p><p>[36:18] Commercial vs. Medicare Value-Based Care</p><p>[39:30] AI in Healthcare: Current and Future Applications</p><p>[43:02] Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="46274812" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/96533eac-b2c4-4feb-81ab-db9216d922f2/audio/eb6b9b6a-d42c-45ad-afa0-c52c5caffe88/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 51: Privia CEO Parth Mehrotra on The Future of Physician Enablement and How To Manage Risk Successfully</itunes:title>
      <itunes:author>Parth Mehrotra, Jacob Effron</itunes:author>
      <itunes:duration>00:48:12</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Parth Mehrotra, CEO of Privia Health. Privia is a physician enablement platform partnering with 4500+ providers towards practice improvement and value-based care. They discuss the most important ways to manage risk, building effective physician enablement solutions, the future of value-based care programs &amp; contracts, and more.</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Parth Mehrotra, CEO of Privia Health. Privia is a physician enablement platform partnering with 4500+ providers towards practice improvement and value-based care. They discuss the most important ways to manage risk, building effective physician enablement solutions, the future of value-based care programs &amp; contracts, and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>51</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">68a5be9a-1745-427e-9008-49c1c34782fe</guid>
      <title>Ep 50: Carelon Health President Bryony Winn on How Payers Think About Provider Strategy, Startups and Value-Based Care</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Bryony Winn, President at Carelon Health. Carelon is the diversified services business within Elevance Health (formerly Anthem), serving 1 in 3 Americans through advanced primary care, behavioral health, specialty enablement, and whole health solutions. They discuss what payers are thinking about, making value-based care work, creating effective provider partnerships, and more.</p><p>[0:00] Introduction to Vital Signs Podcast<br />[0:41] Understanding Elevance Health and Carelon<br />[1:49] The Future of Healthcare Integration<br />[2:57] Carelon's Strategy and Partnerships<br />[3:47] Navigating Healthcare Transitions<br />[5:22] Lessons from Healthcare Partnerships<br />[8:10] The Role of Value-Based Care<br />[9:55] Innovations and Challenges in Healthcare<br />[21:59] The Commercial Healthcare Landscape<br />[25:00] Cross-Business Initiatives and Medicaid Innovations<br />[28:15] The Impact of Generative AI in Healthcare<br />[32:32] Quickfire</p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Thu, 10 Oct 2024 13:02:33 +0000</pubDate>
      <author>jeffron@redpoint.com (Bryony Winn, Nikhil Krishnan, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-50-elevance-exec-bryony-winn-on-how-payers-think-about-provider-strategy-startups-and-value-based-care-bPUEOw00</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Bryony Winn, President at Carelon Health. Carelon is the diversified services business within Elevance Health (formerly Anthem), serving 1 in 3 Americans through advanced primary care, behavioral health, specialty enablement, and whole health solutions. They discuss what payers are thinking about, making value-based care work, creating effective provider partnerships, and more.</p><p>[0:00] Introduction to Vital Signs Podcast<br />[0:41] Understanding Elevance Health and Carelon<br />[1:49] The Future of Healthcare Integration<br />[2:57] Carelon's Strategy and Partnerships<br />[3:47] Navigating Healthcare Transitions<br />[5:22] Lessons from Healthcare Partnerships<br />[8:10] The Role of Value-Based Care<br />[9:55] Innovations and Challenges in Healthcare<br />[21:59] The Commercial Healthcare Landscape<br />[25:00] Cross-Business Initiatives and Medicaid Innovations<br />[28:15] The Impact of Generative AI in Healthcare<br />[32:32] Quickfire</p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="35971282" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/56f78be1-faab-4b10-bc3a-00961513c5fe/audio/7a4cc60a-c33e-46e1-a36e-96e94f14649c/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 50: Carelon Health President Bryony Winn on How Payers Think About Provider Strategy, Startups and Value-Based Care</itunes:title>
      <itunes:author>Bryony Winn, Nikhil Krishnan, Jacob Effron</itunes:author>
      <itunes:duration>00:37:28</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Bryony Winn, President at Carelon Health. Carelon is the diversified services business within Elevance Health (formerly Anthem), serving 1 in 3 Americans through advanced primary care, behavioral health, specialty enablement, and whole health solutions. They discuss what payers are thinking about, making value-based care work, creating effective provider partnerships, and more.</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Bryony Winn, President at Carelon Health. Carelon is the diversified services business within Elevance Health (formerly Anthem), serving 1 in 3 Americans through advanced primary care, behavioral health, specialty enablement, and whole health solutions. They discuss what payers are thinking about, making value-based care work, creating effective provider partnerships, and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>50</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">3fd42843-ceaf-4dc0-bddd-6fb6d3a6a0d7</guid>
      <title>Ep 49: Equip CEO Kristina Saffran on Effective Eating Disorder Treatments and Scaling New Care Models</title>
      <description><![CDATA[<p>Jacob sits down with Kristina Saffran, the Co-Founder and CEO of Equip. Equip delivers at-home, virtual eating disorder treatment for both adolescents and adults. They discuss Kristina’s journey to founding Equip, getting payors on board, evidence-based treatments for eating disorders, and more.</p><p> </p><p>[0:00] Intro</p><p>[1:06] Kristina's Personal Journey</p><p>[3:27] Founding Project Heal </p><p>[4:07] Challenges in Eating Disorder Treatments </p><p>[5:15] The Role of Evidence-Based Treatments </p><p>[6:40] Transition to Venture-Backed Startup </p><p>[13:33] Virtual Care Model for Eating Disorders </p><p>[17:23] Adapting Treatment for Different Populations </p><p>[22:42] Working with Insurance Companies </p><p>[24:37] Equip's Year-Long Care Program </p><p>[25:15] Challenges in Operationalizing Innovative Payment Models </p><p>[28:21] Patient Archetypes and Outreach Strategies </p><p>[32:41] Provider Education and Partnerships </p><p>[34:16] Growth and Future Plans for Equip </p><p>[39:07] The Role of Peer Support in Treatment </p><p>[43:05] Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Wed, 11 Sep 2024 13:04:17 +0000</pubDate>
      <author>jeffron@redpoint.com (Kristina Saffran, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-49-equip-ceo-kristina-saffran-on-effective-eating-disorder-treatments-and-scaling-new-care-models-SDh3YOkz</link>
      <content:encoded><![CDATA[<p>Jacob sits down with Kristina Saffran, the Co-Founder and CEO of Equip. Equip delivers at-home, virtual eating disorder treatment for both adolescents and adults. They discuss Kristina’s journey to founding Equip, getting payors on board, evidence-based treatments for eating disorders, and more.</p><p> </p><p>[0:00] Intro</p><p>[1:06] Kristina's Personal Journey</p><p>[3:27] Founding Project Heal </p><p>[4:07] Challenges in Eating Disorder Treatments </p><p>[5:15] The Role of Evidence-Based Treatments </p><p>[6:40] Transition to Venture-Backed Startup </p><p>[13:33] Virtual Care Model for Eating Disorders </p><p>[17:23] Adapting Treatment for Different Populations </p><p>[22:42] Working with Insurance Companies </p><p>[24:37] Equip's Year-Long Care Program </p><p>[25:15] Challenges in Operationalizing Innovative Payment Models </p><p>[28:21] Patient Archetypes and Outreach Strategies </p><p>[32:41] Provider Education and Partnerships </p><p>[34:16] Growth and Future Plans for Equip </p><p>[39:07] The Role of Peer Support in Treatment </p><p>[43:05] Quickfire</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="46194147" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/257e3170-ae71-4d7e-97ea-1b961407a56c/audio/dd94838a-d98b-4d8f-9961-aea9e8b98c32/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 49: Equip CEO Kristina Saffran on Effective Eating Disorder Treatments and Scaling New Care Models</itunes:title>
      <itunes:author>Kristina Saffran, Jacob Effron</itunes:author>
      <itunes:duration>00:48:07</itunes:duration>
      <itunes:summary>Jacob sits down with Kristina Saffran, the Co-Founder and CEO of Equip. Equip delivers at-home, virtual eating disorder treatment for both adolescents and adults. They discuss Kristina’s journey to founding Equip, getting payors on board, evidence-based treatments for eating disorders, and more.</itunes:summary>
      <itunes:subtitle>Jacob sits down with Kristina Saffran, the Co-Founder and CEO of Equip. Equip delivers at-home, virtual eating disorder treatment for both adolescents and adults. They discuss Kristina’s journey to founding Equip, getting payors on board, evidence-based treatments for eating disorders, and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>49</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">0eb7065f-b73c-469a-81fe-8b40202e3052</guid>
      <title>Ep 48: Savvy CEO Suril Kantaria on First Time Founder Lessons and ICHRA</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Savvy CEO Suril Kantaria to discuss the future of the ICHRA market and what he would do differently if he was starting Savvy today.</p><p> </p><p>[00:00] intro</p><p>[00:35] ICHRA</p><p>[06:20] is this better for employees?</p><p>[15:20] is ICHRA policy doomed to fail?</p><p>[19:10] venture’s role in healthcare</p><p>[24:00] early founders building in “stealth”</p><p>[29:00] making the decision to “stop” as a founder</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Thu, 25 Jul 2024 16:16:09 +0000</pubDate>
      <author>jeffron@redpoint.com (Nikhil Krishnan, Suril Kantaria, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-28-savvy-ceo-suril-kantaria-on-first-time-founder-lessons-ichra-and-working-with-elon-at-twitter-uNoZz9Bt</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Savvy CEO Suril Kantaria to discuss the future of the ICHRA market and what he would do differently if he was starting Savvy today.</p><p> </p><p>[00:00] intro</p><p>[00:35] ICHRA</p><p>[06:20] is this better for employees?</p><p>[15:20] is ICHRA policy doomed to fail?</p><p>[19:10] venture’s role in healthcare</p><p>[24:00] early founders building in “stealth”</p><p>[29:00] making the decision to “stop” as a founder</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="33020492" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/6d8886a2-a1b8-4b9e-90d7-90d41a76ba93/audio/81c99939-f4a3-4f21-9015-cbd014cb0efe/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 48: Savvy CEO Suril Kantaria on First Time Founder Lessons and ICHRA</itunes:title>
      <itunes:author>Nikhil Krishnan, Suril Kantaria, Jacob Effron</itunes:author>
      <itunes:duration>00:34:23</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Savvy CEO Suril Kantaria to discuss the future of the ICHRA market and what he would do differently if he was starting Savvy today. </itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Savvy CEO Suril Kantaria to discuss the future of the ICHRA market and what he would do differently if he was starting Savvy today. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>48</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ad22c437-d2e3-4ef3-961c-ff77ed812a20</guid>
      <title>Ep 47: Former One Medical/Stanford CEO Amir Dan Rubin on Payviders, One Medical Reflections and Gen AI</title>
      <description><![CDATA[<p>Jacob sits down with Amir Dan Rubin, the CEO and Founding Managing Partner at Healthier Capital. Amir previously served as the CEO of One Medical and Stanford Health Care, as well as an EVP at United/Optum. They discuss payer-provider integrations, lessons learned from leading One Medical, applications of generative AI, and more.</p><p> </p><p>(0:00) intro</p><p>(0:44) when does venture capital make sense in the healthcare world?</p><p>(3:04) the future of health systems as we move towards value-based care</p><p>(5:14) dealing with staffing shortages and leveraging new technologies</p><p>(11:49) hospitals investing in companies</p><p>(16:13) the gold standard of United Optum</p><p>(18:57) is the payer-provider combo inevitable?</p><p>(27:21) the key to successful acquisitions</p><p>(33:36) Amazon’s acquisition of One Medical</p><p>(38:25) over-hyped/under-hyped</p><p>(40:23) surprises and decisions at One Medical</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Wed, 10 Jul 2024 12:59:50 +0000</pubDate>
      <author>jeffron@redpoint.com (Jacob Effron, Amir Dan Rubin)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-38-former-one-medical-stanford-ceo-amir-dan-rubin-on-payviders-one-medical-reflections-and-gen-ai-41OgoF2x</link>
      <content:encoded><![CDATA[<p>Jacob sits down with Amir Dan Rubin, the CEO and Founding Managing Partner at Healthier Capital. Amir previously served as the CEO of One Medical and Stanford Health Care, as well as an EVP at United/Optum. They discuss payer-provider integrations, lessons learned from leading One Medical, applications of generative AI, and more.</p><p> </p><p>(0:00) intro</p><p>(0:44) when does venture capital make sense in the healthcare world?</p><p>(3:04) the future of health systems as we move towards value-based care</p><p>(5:14) dealing with staffing shortages and leveraging new technologies</p><p>(11:49) hospitals investing in companies</p><p>(16:13) the gold standard of United Optum</p><p>(18:57) is the payer-provider combo inevitable?</p><p>(27:21) the key to successful acquisitions</p><p>(33:36) Amazon’s acquisition of One Medical</p><p>(38:25) over-hyped/under-hyped</p><p>(40:23) surprises and decisions at One Medical</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="43230399" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/5e7c6179-a8fd-46ba-98e3-3176e2d58fd5/audio/7f13df9b-f6f3-464f-bc5e-d8179a67e8f1/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 47: Former One Medical/Stanford CEO Amir Dan Rubin on Payviders, One Medical Reflections and Gen AI</itunes:title>
      <itunes:author>Jacob Effron, Amir Dan Rubin</itunes:author>
      <itunes:duration>00:45:01</itunes:duration>
      <itunes:summary>Jacob sits down with Amir Dan Rubin, the CEO and Founding Managing Partner at Healthier Capital. Amir previously served as the CEO of One Medical and Stanford Health Care, as well as an EVP at United/Optum. They discuss payer-provider integrations, lessons learned from leading One Medical, applications of generative AI, and more.</itunes:summary>
      <itunes:subtitle>Jacob sits down with Amir Dan Rubin, the CEO and Founding Managing Partner at Healthier Capital. Amir previously served as the CEO of One Medical and Stanford Health Care, as well as an EVP at United/Optum. They discuss payer-provider integrations, lessons learned from leading One Medical, applications of generative AI, and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>47</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">01ddff28-1c26-4360-8a0c-7ed00e675ff8</guid>
      <title>Ep 46: Humana Primary Care CMO Dr. Vivek Garg on Next Gen Primary Care Lessons and Effective Payer Partnerships</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Dr. Vivek Garg, the Chief Medical Officer & SVP, Primary Care at Humana; Chief Medical Officer at both CenterWell and Conviva; and a former clinical leader at CareMore, Oscar, and One Medical. They discuss Vivek’s insights around primary care, value-based care, and more.</p><p> </p><p>(0:00) intro</p><p>(0:52) how different care models compare</p><p>(7:28) best areas to outsource</p><p>(11:15) where are we in the adoption of value-based care?</p><p>(14:40) how do we get hospitals on board with value-based care?</p><p>(19:38) payer acquisition of provider assets</p><p>(22:42) payers vs. providers</p><p>(25:18) something Vivek thought would work that didn’t</p><p>(26:43) AI in healthcare</p><p>(29:29) ambient clinical documentation</p><p>(33:59) over-hyped/under-hyped</p><p>(35:59) another company Vivek would want to run</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Mon, 17 Jun 2024 13:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Vivek Garg, Jacob Effron, Nikhil Krishnan)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-46-humana-primary-care-leader-dr-vivek-garg-on-the-future-of-care-delivery-saving-time-with-ai-4FyNxh7K</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Dr. Vivek Garg, the Chief Medical Officer & SVP, Primary Care at Humana; Chief Medical Officer at both CenterWell and Conviva; and a former clinical leader at CareMore, Oscar, and One Medical. They discuss Vivek’s insights around primary care, value-based care, and more.</p><p> </p><p>(0:00) intro</p><p>(0:52) how different care models compare</p><p>(7:28) best areas to outsource</p><p>(11:15) where are we in the adoption of value-based care?</p><p>(14:40) how do we get hospitals on board with value-based care?</p><p>(19:38) payer acquisition of provider assets</p><p>(22:42) payers vs. providers</p><p>(25:18) something Vivek thought would work that didn’t</p><p>(26:43) AI in healthcare</p><p>(29:29) ambient clinical documentation</p><p>(33:59) over-hyped/under-hyped</p><p>(35:59) another company Vivek would want to run</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="37624312" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/563360dd-cb13-49ec-98d1-57412b0aa648/audio/3729c82d-f2a0-4a17-a879-c2077be37292/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 46: Humana Primary Care CMO Dr. Vivek Garg on Next Gen Primary Care Lessons and Effective Payer Partnerships</itunes:title>
      <itunes:author>Vivek Garg, Jacob Effron, Nikhil Krishnan</itunes:author>
      <itunes:duration>00:39:11</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Dr. Vivek Garg, the Chief Medical Officer &amp; SVP, Primary Care at Humana; Chief Medical Officer at both CenterWell and Conviva; and a former clinical leader at CareMore, Oscar, and One Medical. They discuss Vivek’s insights around primary care, value-based care, and more. </itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Dr. Vivek Garg, the Chief Medical Officer &amp; SVP, Primary Care at Humana; Chief Medical Officer at both CenterWell and Conviva; and a former clinical leader at CareMore, Oscar, and One Medical. They discuss Vivek’s insights around primary care, value-based care, and more. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>46</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2f143b1b-b171-4163-a6cf-64f352abbe92</guid>
      <title>Ep 45: Sword Health CEO Virgílio (“V”) Bento on Sword&apos;s New AI Solution and the Decisions That Shaped the Company</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Virgílio (“V”) Bento, Founder and CEO of Sword Health, the $3 billion company focused on improving pain management. They discuss Sword’s new AI care model, the evolution and key decisions behind Sword’s success, customer acquisition, and more.</p><p> </p><p>(0:00) intro</p><p>(1:15) Sword’s journey</p><p>(9:13) advice on selling to employers</p><p>(16:45) getting employees to use the product</p><p>(18:41) building Phoenix, an AI care model</p><p>(22:50) limitations of Phoenix</p><p>(31:17) Sword’s org structure</p><p>(33:56) less successful ventures for Sword</p><p>(36:23) working with brokers</p><p>(39:01) international opportunities</p><p>(42:12) over-hyped/under-hyped</p><p>(42:37) parts of the U.S. healthcare system that don’t make sense</p><p>(44:23) flying across the world for dinner with Vinod Khosla</p><p>(46:57) decisions that were instrumental to Sword’s success</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></description>
      <pubDate>Wed, 5 Jun 2024 12:59:24 +0000</pubDate>
      <author>jeffron@redpoint.com (Virgilio &quot;V&quot; Bento, Nikhil Krishnan, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-45-sword-health-ceo-v-on-swords-new-ai-solution-and-the-decisions-that-shaped-the-company-R2jCX_5M</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Virgílio (“V”) Bento, Founder and CEO of Sword Health, the $3 billion company focused on improving pain management. They discuss Sword’s new AI care model, the evolution and key decisions behind Sword’s success, customer acquisition, and more.</p><p> </p><p>(0:00) intro</p><p>(1:15) Sword’s journey</p><p>(9:13) advice on selling to employers</p><p>(16:45) getting employees to use the product</p><p>(18:41) building Phoenix, an AI care model</p><p>(22:50) limitations of Phoenix</p><p>(31:17) Sword’s org structure</p><p>(33:56) less successful ventures for Sword</p><p>(36:23) working with brokers</p><p>(39:01) international opportunities</p><p>(42:12) over-hyped/under-hyped</p><p>(42:37) parts of the U.S. healthcare system that don’t make sense</p><p>(44:23) flying across the world for dinner with Vinod Khosla</p><p>(46:57) decisions that were instrumental to Sword’s success</p><p> </p><p>Out-Of-Pocket: <a href="https://www.outofpocket.health/">https://www.outofpocket.health/</a></p>
]]></content:encoded>
      <enclosure length="49461334" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/7c89c0ec-bf1a-478a-8a71-644d5600ea0b/audio/ddc77c55-4faf-40dd-b50d-cc8bb224e71f/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 45: Sword Health CEO Virgílio (“V”) Bento on Sword&apos;s New AI Solution and the Decisions That Shaped the Company</itunes:title>
      <itunes:author>Virgilio &quot;V&quot; Bento, Nikhil Krishnan, Jacob Effron</itunes:author>
      <itunes:duration>00:51:31</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Virgílio (“V”) Bento, Founder and CEO of Sword Health, the $3 billion company focused on improving pain management. They discuss Sword’s new AI care model, the evolution and key decisions behind Sword’s success, customer acquisition, and more.</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Virgílio (“V”) Bento, Founder and CEO of Sword Health, the $3 billion company focused on improving pain management. They discuss Sword’s new AI care model, the evolution and key decisions behind Sword’s success, customer acquisition, and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>45</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">741e81b6-5a06-45dd-a0f3-79a94d4fe472</guid>
      <title>Ep 44: Dr. Atul Butte on Healthcare AI Opportunities and Challenges</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Dr. Atul Butte, a professor at UCSF, Chief Data Scientist of the UC Health System, and a co-founder of numerous healthcare startups. They discuss Dr. Butte’s takes on healthcare AI opportunities, challenges, hype, and more.</p><p> </p><p>(0:00) intro</p><p>(0:31) AI hype through the years</p><p>(5:44) when LLMs don’t work</p><p>(8:42) when LLMs surpass humans</p><p>(11:07) AI adoption timeline</p><p>(13:22) converting skeptical doctors</p><p>(20:30) commercialization in AI</p><p>(24:15) how will AI change med school?</p><p>(33:28) regulating consumer-facing AI apps</p><p>(44:08) over-hyped/under-hyped</p><p>(45:44) coolest AI demos</p><p>(47:06) what company would Atul want to run?<br /> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></description>
      <pubDate>Tue, 7 May 2024 12:55:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Atul Butte, Nikhil Krishnan, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-44-dr-atul-butte-on-healthcare-ai-opportunities-and-challenges-uP2rwtaa</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Dr. Atul Butte, a professor at UCSF, Chief Data Scientist of the UC Health System, and a co-founder of numerous healthcare startups. They discuss Dr. Butte’s takes on healthcare AI opportunities, challenges, hype, and more.</p><p> </p><p>(0:00) intro</p><p>(0:31) AI hype through the years</p><p>(5:44) when LLMs don’t work</p><p>(8:42) when LLMs surpass humans</p><p>(11:07) AI adoption timeline</p><p>(13:22) converting skeptical doctors</p><p>(20:30) commercialization in AI</p><p>(24:15) how will AI change med school?</p><p>(33:28) regulating consumer-facing AI apps</p><p>(44:08) over-hyped/under-hyped</p><p>(45:44) coolest AI demos</p><p>(47:06) what company would Atul want to run?<br /> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></content:encoded>
      <enclosure length="47255763" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/742eb7b2-1107-4219-8d37-b8dddfe39ef0/audio/488fc4df-1071-4772-8b45-0057fd8be507/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 44: Dr. Atul Butte on Healthcare AI Opportunities and Challenges</itunes:title>
      <itunes:author>Atul Butte, Nikhil Krishnan, Jacob Effron</itunes:author>
      <itunes:duration>00:49:13</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Dr. Atul Butte, a professor at UCSF, Chief Data Scientist of the UC Health System, and a co-founder of numerous healthcare startups. They discuss Dr. Butte’s takes on healthcare AI opportunities, challenges, hype, and more.</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Dr. Atul Butte, a professor at UCSF, Chief Data Scientist of the UC Health System, and a co-founder of numerous healthcare startups. They discuss Dr. Butte’s takes on healthcare AI opportunities, challenges, hype, and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>44</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e5be79ce-3bbc-4b51-b72b-68f126a01c61</guid>
      <title>Ep 43: Former Secretary of Veterans Affairs Dr. David Shulkin on Transforming the VA &amp; Getting Public-Private Partnerships Right</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Dr. David Shulkin, the former Secretary of Veterans Affairs who has also held roles as CMO of the University of Pennsylvania Health System, CEO of Beth Israel Medical Center, and Vice Dean of the Drexel University College of Medicine. They discuss David’s experiences innovating within the VA, meeting the health needs of a population, and more.</p><p> </p><p>(0:00) intro</p><p>(0:34) footprint of the VA today</p><p>(2:38) privatization debate</p><p>(5:36) solving access to healthcare for veterans</p><p>(12:29) setting priorities as a leader</p><p>(19:34) monolithic single-payer funding</p><p>(23:41) what does the rollout of a massive EHR look like?</p><p>(32:44) things that the VA does well</p><p>(38:35) startups having success in the VA</p><p>(41:26) how will the medical education system change going forward?</p><p>(44:51) applications of AI in healthcare</p><p>(48:23) over-hyped/under-hyped</p><p>(49:20) what company would David want to lead?</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></description>
      <pubDate>Tue, 23 Apr 2024 13:01:49 +0000</pubDate>
      <author>jeffron@redpoint.com (David Shulkin, Nikhil Krishnan, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-43-former-secretary-of-veterans-affairs-dr-david-shulkin-on-transforming-the-va-getting-public-private-partnerships-right-pECvFT1a</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Dr. David Shulkin, the former Secretary of Veterans Affairs who has also held roles as CMO of the University of Pennsylvania Health System, CEO of Beth Israel Medical Center, and Vice Dean of the Drexel University College of Medicine. They discuss David’s experiences innovating within the VA, meeting the health needs of a population, and more.</p><p> </p><p>(0:00) intro</p><p>(0:34) footprint of the VA today</p><p>(2:38) privatization debate</p><p>(5:36) solving access to healthcare for veterans</p><p>(12:29) setting priorities as a leader</p><p>(19:34) monolithic single-payer funding</p><p>(23:41) what does the rollout of a massive EHR look like?</p><p>(32:44) things that the VA does well</p><p>(38:35) startups having success in the VA</p><p>(41:26) how will the medical education system change going forward?</p><p>(44:51) applications of AI in healthcare</p><p>(48:23) over-hyped/under-hyped</p><p>(49:20) what company would David want to lead?</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></content:encoded>
      <enclosure length="49367762" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/f786f164-faa2-43c4-9fbc-c15ce63a152d/audio/c13ecaa4-c36e-43bb-a989-ccfefbf310c9/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 43: Former Secretary of Veterans Affairs Dr. David Shulkin on Transforming the VA &amp; Getting Public-Private Partnerships Right</itunes:title>
      <itunes:author>David Shulkin, Nikhil Krishnan, Jacob Effron</itunes:author>
      <itunes:duration>00:51:25</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Dr. David Shulkin, the former Secretary of Veterans Affairs who has also held roles as CMO of the University of Pennsylvania Health System, CEO of Beth Israel Medical Center, and Vice Dean of the Drexel University College of Medicine. They discuss David’s experiences innovating within the VA, meeting the health needs of a population, and more. </itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Dr. David Shulkin, the former Secretary of Veterans Affairs who has also held roles as CMO of the University of Pennsylvania Health System, CEO of Beth Israel Medical Center, and Vice Dean of the Drexel University College of Medicine. They discuss David’s experiences innovating within the VA, meeting the health needs of a population, and more. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>43</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1eafc242-4b1e-4ab3-a6f2-bf3d863321fc</guid>
      <title>Ep 42: Alan CEO Jean-Charles Samuelian-Werve on Building a Healthcare Superapp &amp; the Future of Healthcare in Europe</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Jean-Charles Samuelian-Werve, Co-Founder and CEO of Alan. Alan is a multi-billion dollar French health insurance company that has expanded to become an all-in-one health platform for its consumers. They discuss Alan’s product strategy and business model, building AI for healthcare companies, what healthcare looks like in Europe, and more.</p><p> </p><p>(0:00) intro</p><p>(0:47) French healthcare 101</p><p>(6:30) similarities with Oscar </p><p>(9:50) building a healthcare super-app</p><p>(15:11) medical loss ratio</p><p>(21:58) contracting with providers</p><p>(29:29) optimizing Alan for different countries/continents  </p><p>(35:08) finding new users</p><p>(38:17) AI in healthcare</p><p>(48:31) over-hyped/under-hyped</p><p>(50:36) healthcare policy changes Jean-Charles would make in France</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></description>
      <pubDate>Tue, 9 Apr 2024 13:00:14 +0000</pubDate>
      <author>jeffron@redpoint.com (Jean-Charles Samuelian-Werve, Jacob Effron, Nikhil Krishnan)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-42-alan-ceo-jean-charles-samuelian-werve-on-building-a-healthcare-superapp-the-future-of-healthcare-in-europe-AP_QaTsA</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Jean-Charles Samuelian-Werve, Co-Founder and CEO of Alan. Alan is a multi-billion dollar French health insurance company that has expanded to become an all-in-one health platform for its consumers. They discuss Alan’s product strategy and business model, building AI for healthcare companies, what healthcare looks like in Europe, and more.</p><p> </p><p>(0:00) intro</p><p>(0:47) French healthcare 101</p><p>(6:30) similarities with Oscar </p><p>(9:50) building a healthcare super-app</p><p>(15:11) medical loss ratio</p><p>(21:58) contracting with providers</p><p>(29:29) optimizing Alan for different countries/continents  </p><p>(35:08) finding new users</p><p>(38:17) AI in healthcare</p><p>(48:31) over-hyped/under-hyped</p><p>(50:36) healthcare policy changes Jean-Charles would make in France</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></content:encoded>
      <enclosure length="51984971" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/876bed9e-6e0c-4a20-84ed-4c6150eb5309/audio/0ddbf6bb-edc1-4771-b2e6-0c85fcfaff1a/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 42: Alan CEO Jean-Charles Samuelian-Werve on Building a Healthcare Superapp &amp; the Future of Healthcare in Europe</itunes:title>
      <itunes:author>Jean-Charles Samuelian-Werve, Jacob Effron, Nikhil Krishnan</itunes:author>
      <itunes:duration>00:54:09</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Jean-Charles Samuelian-Werve, Co-Founder and CEO of Alan. Alan is a multi-billion dollar French health insurance company that has expanded to become an all-in-one health platform for its consumers. They discuss Alan’s product strategy and business model, building AI for healthcare companies, what healthcare looks like in Europe, and more.
</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Jean-Charles Samuelian-Werve, Co-Founder and CEO of Alan. Alan is a multi-billion dollar French health insurance company that has expanded to become an all-in-one health platform for its consumers. They discuss Alan’s product strategy and business model, building AI for healthcare companies, what healthcare looks like in Europe, and more.
</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>42</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">8065e431-5a5f-4126-b85a-ebf49e7194bb</guid>
      <title>Ep 41: Benchling Head of Strategy Malay Gandhi on the Future of Life Sciences Software and The Evolution of Digital Health</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Malay Gandhi, Head of Strategy & Corporate Development at Benchling. Malay previously served as CEO of Rock Health and SVP of Business Operations at Evidation Health, and his seminal pieces helped shape early digital health thinking. They discuss some of Malay’s early pieces, the future of life sciences & real-world evidence, building & scaling software at Benchling, and more.</p><p> </p><p>(0:00) intro</p><p>(0:58) how Malay feels about his old essays</p><p>(8:00) the Benchling story</p><p>(16:29) serving customers in different industries</p><p>(22:12) how will AI change Benchling</p><p>(29:49) the state of tech in biopharma</p><p>(38:41) the real-world experiment</p><p>(42:04) have trial designs changed?</p><p>(46:24) over-hyped/under-hyped</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></description>
      <pubDate>Tue, 26 Mar 2024 13:01:22 +0000</pubDate>
      <author>jeffron@redpoint.com (Malay Gandhi, Nikhil Krishnan, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-41-benchling-head-of-strategy-malay-gandhi-on-the-future-of-life-sciences-software-and-the-evolution-of-digital-health-wF5BpeX_</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Malay Gandhi, Head of Strategy & Corporate Development at Benchling. Malay previously served as CEO of Rock Health and SVP of Business Operations at Evidation Health, and his seminal pieces helped shape early digital health thinking. They discuss some of Malay’s early pieces, the future of life sciences & real-world evidence, building & scaling software at Benchling, and more.</p><p> </p><p>(0:00) intro</p><p>(0:58) how Malay feels about his old essays</p><p>(8:00) the Benchling story</p><p>(16:29) serving customers in different industries</p><p>(22:12) how will AI change Benchling</p><p>(29:49) the state of tech in biopharma</p><p>(38:41) the real-world experiment</p><p>(42:04) have trial designs changed?</p><p>(46:24) over-hyped/under-hyped</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></content:encoded>
      <enclosure length="53770911" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/ea0f9db5-7394-468e-85d3-3d3aa080017f/audio/65344d80-a92e-41fa-95ad-8414731fced8/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 41: Benchling Head of Strategy Malay Gandhi on the Future of Life Sciences Software and The Evolution of Digital Health</itunes:title>
      <itunes:author>Malay Gandhi, Nikhil Krishnan, Jacob Effron</itunes:author>
      <itunes:duration>00:56:00</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Malay Gandhi, Head of Strategy &amp; Corporate Development at Benchling. Malay previously served as CEO of Rock Health and SVP of Business Operations at Evidation Health, and his seminal pieces helped shape early digital health thinking. They discuss some of Malay’s early pieces, the future of life sciences &amp; real-world evidence, building &amp; scaling software at Benchling, and more.</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Malay Gandhi, Head of Strategy &amp; Corporate Development at Benchling. Malay previously served as CEO of Rock Health and SVP of Business Operations at Evidation Health, and his seminal pieces helped shape early digital health thinking. They discuss some of Malay’s early pieces, the future of life sciences &amp; real-world evidence, building &amp; scaling software at Benchling, and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>41</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6ea47154-5145-4221-84ee-35bf90232e5a</guid>
      <title>Ep 40: Strive Health Co-Founder Will Stokes on The Key Parts of Risk-Based Contracts and Value Based Care In Specialties</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Will Stokes, Co-Founder and Chief Growth Officer of Strive Health, a pioneer in value-based care that partners with payers and providers to care for patients with chronic kidney disease. They discuss the nuances of risk-based contracting, value-based models for specialists, selling to both payers and providers, and more.</p><p> </p><p>(0:00) intro</p><p>(0:39) when do risk-based models make sense</p><p>(8:50) surprises when building Strive</p><p>(13:53) negotiating risk-based contracts</p><p>(21:08) primary care for patients with specialized conditions</p><p>(30:28) approaching risk-adjustment changes</p><p>(34:35) using LLMs at Strive</p><p>(38:44) when does it make sense to incubate a company?</p><p><br />Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></description>
      <pubDate>Tue, 12 Mar 2024 13:39:55 +0000</pubDate>
      <author>jeffron@redpoint.com (Will Stokes, Jacob Effron, Nikhil Krishnan)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-40-strive-health-co-founder-will-stokes-on-the-key-parts-of-risk-based-contracts-and-value-based-care-in-specialties-_6ro6tTq</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Will Stokes, Co-Founder and Chief Growth Officer of Strive Health, a pioneer in value-based care that partners with payers and providers to care for patients with chronic kidney disease. They discuss the nuances of risk-based contracting, value-based models for specialists, selling to both payers and providers, and more.</p><p> </p><p>(0:00) intro</p><p>(0:39) when do risk-based models make sense</p><p>(8:50) surprises when building Strive</p><p>(13:53) negotiating risk-based contracts</p><p>(21:08) primary care for patients with specialized conditions</p><p>(30:28) approaching risk-adjustment changes</p><p>(34:35) using LLMs at Strive</p><p>(38:44) when does it make sense to incubate a company?</p><p><br />Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></content:encoded>
      <enclosure length="41463684" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/5310d604-ab83-4431-9b54-bedb396dd335/audio/0f864f48-6ce1-4433-9bf5-4007dccc2ce5/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 40: Strive Health Co-Founder Will Stokes on The Key Parts of Risk-Based Contracts and Value Based Care In Specialties</itunes:title>
      <itunes:author>Will Stokes, Jacob Effron, Nikhil Krishnan</itunes:author>
      <itunes:duration>00:43:11</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Will Stokes, Co-Founder and Chief Growth Officer of Strive Health, a pioneer in value-based care that partners with payers and providers to care for patients with chronic kidney disease. They discuss the nuances of risk-based contracting, value-based models for specialists, selling to both payers and providers, and more. </itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Will Stokes, Co-Founder and Chief Growth Officer of Strive Health, a pioneer in value-based care that partners with payers and providers to care for patients with chronic kidney disease. They discuss the nuances of risk-based contracting, value-based models for specialists, selling to both payers and providers, and more. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>40</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">230ef822-942a-4545-b09d-dfe27bee66c6</guid>
      <title>Ep 39: Dr. Amy Abernethy on the Future of Real-World Evidence and Regulating Generative AI</title>
      <description><![CDATA[<p>Jacob sits down with Dr. Amy Abernethy, whose health tech career spans from clinician and researcher to CMO at Flatiron Health to Principal Deputy Commissioner and Chief Innovation Officer at the FDA to CMO and President of Product Development at Verily to co-founder of her own non-profit to accelerate evidence generation. They discuss the current and future states of real-world evidence, how clinical research can improve, the adoption of GenAI in healthcare, Verily’s growth story, her new venture, and more.</p><p> </p><p>(0:00) intro</p><p>(0:40) real-world evidence</p><p>(13:48) the future of control arms in clinical trials</p><p>(22:16) startup ideas</p><p>(25:04) generative AI in healthcare</p><p>(27:18) regulating AI</p><p>(35:09) the evolution of Verily</p><p>(38:26) what is next for Amy?</p><p>(42:59) over-hyped/under-hyped</p><p>(43:37) one policy change to improve healthcare in the U.S.</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></description>
      <pubDate>Tue, 27 Feb 2024 13:58:59 +0000</pubDate>
      <author>jeffron@redpoint.com (Amy Abernethy, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-39-dr-amy-abernethy-on-the-future-of-real-world-evidence-and-regulating-generative-ai-6crFym16</link>
      <content:encoded><![CDATA[<p>Jacob sits down with Dr. Amy Abernethy, whose health tech career spans from clinician and researcher to CMO at Flatiron Health to Principal Deputy Commissioner and Chief Innovation Officer at the FDA to CMO and President of Product Development at Verily to co-founder of her own non-profit to accelerate evidence generation. They discuss the current and future states of real-world evidence, how clinical research can improve, the adoption of GenAI in healthcare, Verily’s growth story, her new venture, and more.</p><p> </p><p>(0:00) intro</p><p>(0:40) real-world evidence</p><p>(13:48) the future of control arms in clinical trials</p><p>(22:16) startup ideas</p><p>(25:04) generative AI in healthcare</p><p>(27:18) regulating AI</p><p>(35:09) the evolution of Verily</p><p>(38:26) what is next for Amy?</p><p>(42:59) over-hyped/under-hyped</p><p>(43:37) one policy change to improve healthcare in the U.S.</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></content:encoded>
      <enclosure length="43962244" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/684b55da-f169-44e8-9ff0-aecd7ce4e235/audio/1545e7c6-3cca-4522-a416-ac88f58d6a7e/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 39: Dr. Amy Abernethy on the Future of Real-World Evidence and Regulating Generative AI</itunes:title>
      <itunes:author>Amy Abernethy, Jacob Effron</itunes:author>
      <itunes:duration>00:45:47</itunes:duration>
      <itunes:summary>Jacob sits down with Dr. Amy Abernethy, whose health tech career spans from clinician and researcher to CMO at Flatiron Health to Principal Deputy Commissioner and Chief Innovation Officer at the FDA to CMO and President of Product Development at Verily to co-founder of her own non-profit to accelerate evidence generation. They discuss the current and future states of real-world evidence, how clinical research can improve, the adoption of GenAI in healthcare, Verily’s growth story, her new venture, and more. </itunes:summary>
      <itunes:subtitle>Jacob sits down with Dr. Amy Abernethy, whose health tech career spans from clinician and researcher to CMO at Flatiron Health to Principal Deputy Commissioner and Chief Innovation Officer at the FDA to CMO and President of Product Development at Verily to co-founder of her own non-profit to accelerate evidence generation. They discuss the current and future states of real-world evidence, how clinical research can improve, the adoption of GenAI in healthcare, Verily’s growth story, her new venture, and more. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>39</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">456e617b-66c5-4fda-b6b9-25f103704831</guid>
      <title>Ep 38: Oscar Co-Founder Mario Schlosser on Lessons from Implementing LLMs and How AI Will Impact Healthcare</title>
      <description><![CDATA[<p>Oscar Health is a $4B public healthcare company, providing healthcare insurance to nearly 1 million members. Oscar is at the forefront of AI adoption, continuously developing new AI use cases in healthcare. On this week’s episode, we sat down with Oscar Health Co-Founder, former CEO, and now President of Technology Mario Schlosser to talk about where AI will have the biggest impact in healthcare, limitations of GPT-4 in healthcare, and why can't we have robot doctors today.</p><p> </p><p>(0:00) intro</p><p>(1:06) how will AI change healthcare in the next decade</p><p>(9:09) how Oscar uses AI</p><p>(18:40) how to build around healthcare requirements</p><p>(25:46) when would GPT-4 fail "miserably" and fundamental limitations of LLMs</p><p>(36:28) we shouldn’t piss off our smartest robots</p><p>(38:15) sharing AI knowledge between companies</p><p>(41:50) developing healthcare-specific models</p><p>(44:35) hackathons and karaoke nights at Oscar</p><p>(49:07) the need for a safety layer in LLMs</p><p>(51:33) best commercial opportunities in healthcare</p><p>(55:19) will their be AI doctors this decade?</p><p>(59:18) over-hyped/under-hyped</p><p>(1:00:49) most exciting AI company?</p><p>(1:08:46) over-hyped/under-hyped</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></description>
      <pubDate>Tue, 13 Feb 2024 14:11:57 +0000</pubDate>
      <author>jeffron@redpoint.com (Mario Schlosser, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-38-oscar-ceo-mario-schlosser-on-lessons-from-implementing-llms-and-how-ai-will-impact-healthcare-a2AR044r</link>
      <content:encoded><![CDATA[<p>Oscar Health is a $4B public healthcare company, providing healthcare insurance to nearly 1 million members. Oscar is at the forefront of AI adoption, continuously developing new AI use cases in healthcare. On this week’s episode, we sat down with Oscar Health Co-Founder, former CEO, and now President of Technology Mario Schlosser to talk about where AI will have the biggest impact in healthcare, limitations of GPT-4 in healthcare, and why can't we have robot doctors today.</p><p> </p><p>(0:00) intro</p><p>(1:06) how will AI change healthcare in the next decade</p><p>(9:09) how Oscar uses AI</p><p>(18:40) how to build around healthcare requirements</p><p>(25:46) when would GPT-4 fail "miserably" and fundamental limitations of LLMs</p><p>(36:28) we shouldn’t piss off our smartest robots</p><p>(38:15) sharing AI knowledge between companies</p><p>(41:50) developing healthcare-specific models</p><p>(44:35) hackathons and karaoke nights at Oscar</p><p>(49:07) the need for a safety layer in LLMs</p><p>(51:33) best commercial opportunities in healthcare</p><p>(55:19) will their be AI doctors this decade?</p><p>(59:18) over-hyped/under-hyped</p><p>(1:00:49) most exciting AI company?</p><p>(1:08:46) over-hyped/under-hyped</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></content:encoded>
      <enclosure length="70719991" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/a001125f-7a00-425f-8c4b-0f8f14019efc/audio/1cb24a6f-89ed-47b2-8ab0-7c73cb53f961/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 38: Oscar Co-Founder Mario Schlosser on Lessons from Implementing LLMs and How AI Will Impact Healthcare</itunes:title>
      <itunes:author>Mario Schlosser, Jacob Effron</itunes:author>
      <itunes:duration>01:13:39</itunes:duration>
      <itunes:summary>Oscar Health is a $4B public healthcare company, providing healthcare insurance to nearly 1 million members. Oscar is at the forefront of AI adoption, continuously developing new AI use cases in healthcare. On this week’s episode, we sat down with Oscar Health Co-Founder, former CEO, and now President of Technology Mario Schlosser to talk about where AI will have the biggest impact in healthcare, limitations of GPT-4 in healthcare, and why can&apos;t we have robot doctors today.</itunes:summary>
      <itunes:subtitle>Oscar Health is a $4B public healthcare company, providing healthcare insurance to nearly 1 million members. Oscar is at the forefront of AI adoption, continuously developing new AI use cases in healthcare. On this week’s episode, we sat down with Oscar Health Co-Founder, former CEO, and now President of Technology Mario Schlosser to talk about where AI will have the biggest impact in healthcare, limitations of GPT-4 in healthcare, and why can&apos;t we have robot doctors today.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>38</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d195584a-bb54-4d3b-a5dc-8c2d4b029d5d</guid>
      <title>Ep 37: Centene Corporation CEO Sarah London on Centene’s Strategy and Innovating in Medicaid</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Sarah London, CEO of Centene Corporation, the largest managed Medicaid organization in the country, serving 15 million Medicaid members. They discuss Medicaid partnerships and redeterminations, SDoH innovation and outcomes, and payers vertically expanding their ownership.</p><p> </p><p>(0:00) intro</p><p>(0:39) Centene’s footprint today</p><p>(1:37) working with startups</p><p>(6:24) Centene’s priorities</p><p>(12:23) how state RFPs have changed over time</p><p>(15:04) differences between states</p><p>(18:40) Medicaid redeterminations</p><p>(22:35) will every payer end up looking like United Optum?</p><p>(29:09) what kind of data is most helpful?</p><p>(31:46) where Gen AI can be implemented in healthcare</p><p>(35:20) ICHRA markets</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></description>
      <pubDate>Tue, 30 Jan 2024 13:57:54 +0000</pubDate>
      <author>jeffron@redpoint.com (Sarah London, Nikhil Krishnan, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-37-centene-corporation-ceo-sarah-london-on-centenes-strategy-and-innovating-in-medicaid-ujq_kRKh</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Sarah London, CEO of Centene Corporation, the largest managed Medicaid organization in the country, serving 15 million Medicaid members. They discuss Medicaid partnerships and redeterminations, SDoH innovation and outcomes, and payers vertically expanding their ownership.</p><p> </p><p>(0:00) intro</p><p>(0:39) Centene’s footprint today</p><p>(1:37) working with startups</p><p>(6:24) Centene’s priorities</p><p>(12:23) how state RFPs have changed over time</p><p>(15:04) differences between states</p><p>(18:40) Medicaid redeterminations</p><p>(22:35) will every payer end up looking like United Optum?</p><p>(29:09) what kind of data is most helpful?</p><p>(31:46) where Gen AI can be implemented in healthcare</p><p>(35:20) ICHRA markets</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></content:encoded>
      <enclosure length="40622751" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/b04d2980-2d42-46dc-a844-390d9745fae8/audio/600b4d4d-8ed5-42df-aa59-57022a4e620e/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 37: Centene Corporation CEO Sarah London on Centene’s Strategy and Innovating in Medicaid</itunes:title>
      <itunes:author>Sarah London, Nikhil Krishnan, Jacob Effron</itunes:author>
      <itunes:duration>00:42:18</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Sarah London, CEO of Centene Corporation, the largest managed Medicaid organization in the country, serving 15 million Medicaid members. They discuss Medicaid partnerships and redeterminations, SDoH innovation and outcomes, and payers vertically expanding their ownership. </itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Sarah London, CEO of Centene Corporation, the largest managed Medicaid organization in the country, serving 15 million Medicaid members. They discuss Medicaid partnerships and redeterminations, SDoH innovation and outcomes, and payers vertically expanding their ownership. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>37</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b1d83ee9-0a99-4177-afb4-4d76190d3d13</guid>
      <title>Ep 36: Dr. Ezekiel Emanuel on Why Healthcare Reform is so Hard and the Future of Hospitals</title>
      <description><![CDATA[<p>Jacob sits down with Dr. Ezekiel Emanuel again to discuss the future of health policy and care delivery, hyped innovations in healthcare, market trends among payers and providers, and more. </p><p> </p><p>(0:00) intro</p><p>(0:57) generative AI</p><p>(4:08) the ethics of NOT using AI</p><p>(7:04) ML-based risk adjustment</p><p>(11:46) why didn’t hospitals become payers?</p><p>(19:37) what does the future of hospitals look like?</p><p>(26:15) can insurance cover mental health treatment for everybody?</p><p>(29:45) GLP-1s</p><p>(35:02) the future of healthcare policy</p><p>(41:07) what should we be learning from the way other countries do healthcare?</p><p>(45:57) Ben Franklin</p><p>(49:37) Zeke Bar update</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></description>
      <pubDate>Tue, 12 Dec 2023 14:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Ezekiel Emanuel, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-36-dr-ezekiel-emanuel-on-why-healthcare-reform-is-so-hard-and-the-future-of-hospitals-t8gjGErD</link>
      <content:encoded><![CDATA[<p>Jacob sits down with Dr. Ezekiel Emanuel again to discuss the future of health policy and care delivery, hyped innovations in healthcare, market trends among payers and providers, and more. </p><p> </p><p>(0:00) intro</p><p>(0:57) generative AI</p><p>(4:08) the ethics of NOT using AI</p><p>(7:04) ML-based risk adjustment</p><p>(11:46) why didn’t hospitals become payers?</p><p>(19:37) what does the future of hospitals look like?</p><p>(26:15) can insurance cover mental health treatment for everybody?</p><p>(29:45) GLP-1s</p><p>(35:02) the future of healthcare policy</p><p>(41:07) what should we be learning from the way other countries do healthcare?</p><p>(45:57) Ben Franklin</p><p>(49:37) Zeke Bar update</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></content:encoded>
      <enclosure length="49099799" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/0a968044-b295-4eeb-888d-bfce303c94f9/audio/3ed1d35a-42e0-4890-9539-611785775d13/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 36: Dr. Ezekiel Emanuel on Why Healthcare Reform is so Hard and the Future of Hospitals</itunes:title>
      <itunes:author>Ezekiel Emanuel, Jacob Effron</itunes:author>
      <itunes:duration>00:51:08</itunes:duration>
      <itunes:summary>Jacob sits down with Dr. Ezekiel Emanuel again to discuss the future of health policy and care delivery, hyped innovations in healthcare, market trends among payers and providers, and more. </itunes:summary>
      <itunes:subtitle>Jacob sits down with Dr. Ezekiel Emanuel again to discuss the future of health policy and care delivery, hyped innovations in healthcare, market trends among payers and providers, and more. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>36</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b160fe9b-a406-4a46-94f9-0084ae0b0d8e</guid>
      <title>Ep 35: Cityblock CEO Dr. Toyin Ajayi on the Current and Future State of Medicaid Innovation</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Toyin Ajayi, Co-Founder and CEO of Cityblock Health, an SDoH-focused provider of primary care, behavioral health, and chronic disease management for Medicaid and dual eligible patients. They discuss innovating in Medicaid, engaging patients with digital solutions, building sustainable companies, and more.</p><p> </p><p>(0:00) intro</p><p>(0:50) the state of Medicaid innovation today</p><p>(2:33) Toyin’s time at Commonwealth</p><p>(7:33) incubators in the current climate</p><p>(11:02) biggest risks starting Cityblock</p><p>(14:46) surprises in building Cityblock</p><p>(23:06) how Cityblock chooses which services to offer and which to outsource</p><p>(29:22) lower acuity patients</p><p>(33:23) state-by-state differences</p><p>(37:59) policy changes to improve Medicaid</p><p>(42:15) a shift towards profitability</p><p>(45:01) generative AI</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></description>
      <pubDate>Tue, 28 Nov 2023 16:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Nikhil Krishnan, Jacob Effron, Toyin Ajayi)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-35-cityblock-ceo-toyin-ayaji-lpiDPjXz</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Toyin Ajayi, Co-Founder and CEO of Cityblock Health, an SDoH-focused provider of primary care, behavioral health, and chronic disease management for Medicaid and dual eligible patients. They discuss innovating in Medicaid, engaging patients with digital solutions, building sustainable companies, and more.</p><p> </p><p>(0:00) intro</p><p>(0:50) the state of Medicaid innovation today</p><p>(2:33) Toyin’s time at Commonwealth</p><p>(7:33) incubators in the current climate</p><p>(11:02) biggest risks starting Cityblock</p><p>(14:46) surprises in building Cityblock</p><p>(23:06) how Cityblock chooses which services to offer and which to outsource</p><p>(29:22) lower acuity patients</p><p>(33:23) state-by-state differences</p><p>(37:59) policy changes to improve Medicaid</p><p>(42:15) a shift towards profitability</p><p>(45:01) generative AI</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></content:encoded>
      <enclosure length="48950169" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/aff258da-fe35-4dac-a32b-0c1488b75bde/audio/574e8ba1-904c-47b1-aa75-a58c224f0c4d/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 35: Cityblock CEO Dr. Toyin Ajayi on the Current and Future State of Medicaid Innovation</itunes:title>
      <itunes:author>Nikhil Krishnan, Jacob Effron, Toyin Ajayi</itunes:author>
      <itunes:duration>00:50:59</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Toyin Ajayi, Co-Founder and CEO of Cityblock Health, an SDoH-focused provider of primary care, behavioral health, and chronic disease management for Medicaid and dual eligible patients. They discuss innovating in Medicaid, engaging patients with digital solutions, building sustainable companies, and more. </itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Toyin Ajayi, Co-Founder and CEO of Cityblock Health, an SDoH-focused provider of primary care, behavioral health, and chronic disease management for Medicaid and dual eligible patients. They discuss innovating in Medicaid, engaging patients with digital solutions, building sustainable companies, and more. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>35</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c505b841-fece-4291-838d-6b8da6ed16fe</guid>
      <title>Ep 34: Pomelo Care CEO Marta Bralic Kerns on Improving Maternity Care &amp; How to Sell to Payers</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Marta Bralic Kerns, Founder and CEO of Pomelo Care, a multispecialty virtual medical practice that cares for mothers and babies from preconception to one year postpartum. They discuss payer contracting and Medicaid, career advice for those joining startups, why maternity care is such a pressing issue in the US, and more.</p><p> </p><p>(0:00) intro</p><p>(0:47) maternity outcomes in the U.S.</p><p>(5:39) clinician supply issue</p><p>(6:56) how Pomelo Care works</p><p>(12:20) how patients find Pomelo</p><p>(15:21) how Pomelo fits into the healthcare journey after pregnancy</p><p>(17:06) pitching Pomelo to payers</p><p>(24:16) Pomelo’s Medicaid focus</p><p>(26:59) state-by-state differences in maternity care</p><p>(30:30) constraints to growing Pomelo</p><p>(31:34) team-based maternity care</p><p>(34:19) how to sell to payers</p><p>(40:43) advice for people early in their health-tech careers</p><p>(45:32) Flatiron and EHRs</p><p>(51:17) over-hyped/under-hyped</p><p>(53:06) NOT hiring Nikhil</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></description>
      <pubDate>Tue, 14 Nov 2023 16:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Marta Bralic Kerns, Jacob Effron, Nikhil Krishnan)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-34-pomelo-care-ceo-marta-bralic-kerns-on-improving-maternity-care-how-to-sell-to-payers-34q1wW6g</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Marta Bralic Kerns, Founder and CEO of Pomelo Care, a multispecialty virtual medical practice that cares for mothers and babies from preconception to one year postpartum. They discuss payer contracting and Medicaid, career advice for those joining startups, why maternity care is such a pressing issue in the US, and more.</p><p> </p><p>(0:00) intro</p><p>(0:47) maternity outcomes in the U.S.</p><p>(5:39) clinician supply issue</p><p>(6:56) how Pomelo Care works</p><p>(12:20) how patients find Pomelo</p><p>(15:21) how Pomelo fits into the healthcare journey after pregnancy</p><p>(17:06) pitching Pomelo to payers</p><p>(24:16) Pomelo’s Medicaid focus</p><p>(26:59) state-by-state differences in maternity care</p><p>(30:30) constraints to growing Pomelo</p><p>(31:34) team-based maternity care</p><p>(34:19) how to sell to payers</p><p>(40:43) advice for people early in their health-tech careers</p><p>(45:32) Flatiron and EHRs</p><p>(51:17) over-hyped/under-hyped</p><p>(53:06) NOT hiring Nikhil</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></content:encoded>
      <enclosure length="53227564" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/7c0d198d-2b62-4eac-91c6-45e0352e3a7e/audio/c1171f24-46b1-4f71-bf91-59d101937d3c/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 34: Pomelo Care CEO Marta Bralic Kerns on Improving Maternity Care &amp; How to Sell to Payers</itunes:title>
      <itunes:author>Marta Bralic Kerns, Jacob Effron, Nikhil Krishnan</itunes:author>
      <itunes:duration>00:55:26</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Marta Bralic Kerns, Founder and CEO of Pomelo Care, a multispecialty virtual medical practice that cares for mothers and babies from preconception to one year postpartum. They discuss payer contracting and Medicaid, career advice for those joining startups, why maternity care is such a pressing issue in the US, and more. </itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Marta Bralic Kerns, Founder and CEO of Pomelo Care, a multispecialty virtual medical practice that cares for mothers and babies from preconception to one year postpartum. They discuss payer contracting and Medicaid, career advice for those joining startups, why maternity care is such a pressing issue in the US, and more. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>34</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">bf115833-2c7b-45a5-87f8-c183f25bc635</guid>
      <title>Ep 33: Aledade CEO Farzad Mostashari on Managing $20B in Healthcare Spending and Lessons on Succeeding in Value-Based Care</title>
      <description><![CDATA[<p>Jacob and Nikhil speak with Farzad Mostashari, Founder and CEO of Aledade, which supports independent primary care practices to succeed in value-based care. Farzad talks about the current evidence of success in VBC, why VBC is still underhyped, barriers for Medicaid models, and more.</p><p> </p><p>(0:00) intro</p><p>(0:40) why we don’t see more doctors starting their own practices</p><p>(8:32) what actually works in value-based care?</p><p>(11:48) what does Aledade do?</p><p>(23:18) how competitive has it become to acquire new practices?</p><p>(28:29) Aledade First</p><p>(37:27) one policy change Farzad would make in healthcare</p><p>(42:18) best way to learn more about Aledade</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></description>
      <pubDate>Thu, 2 Nov 2023 16:31:03 +0000</pubDate>
      <author>jeffron@redpoint.com (Farzad Mostashari, Nikhil Krishnan, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-33-aledade-ceo-farzad-mostashari-on-managing-20b-in-healthcare-spending-and-lessons-on-succeeding-in-value-based-care-xzv0WFGJ</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil speak with Farzad Mostashari, Founder and CEO of Aledade, which supports independent primary care practices to succeed in value-based care. Farzad talks about the current evidence of success in VBC, why VBC is still underhyped, barriers for Medicaid models, and more.</p><p> </p><p>(0:00) intro</p><p>(0:40) why we don’t see more doctors starting their own practices</p><p>(8:32) what actually works in value-based care?</p><p>(11:48) what does Aledade do?</p><p>(23:18) how competitive has it become to acquire new practices?</p><p>(28:29) Aledade First</p><p>(37:27) one policy change Farzad would make in healthcare</p><p>(42:18) best way to learn more about Aledade</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></content:encoded>
      <enclosure length="41650094" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/3cf23dc3-9597-49b5-9894-61fb85db5f65/audio/ba9bc65b-cff7-4196-91f2-a0ca86939363/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 33: Aledade CEO Farzad Mostashari on Managing $20B in Healthcare Spending and Lessons on Succeeding in Value-Based Care</itunes:title>
      <itunes:author>Farzad Mostashari, Nikhil Krishnan, Jacob Effron</itunes:author>
      <itunes:duration>00:43:23</itunes:duration>
      <itunes:summary>Jacob and Nikhil speak with Farzad Mostashari, Founder and CEO of Aledade, which supports independent primary care practices to succeed in value-based care. Farzad talks about the current evidence of success in VBC, why VBC is still underhyped, barriers for Medicaid models, and more. </itunes:summary>
      <itunes:subtitle>Jacob and Nikhil speak with Farzad Mostashari, Founder and CEO of Aledade, which supports independent primary care practices to succeed in value-based care. Farzad talks about the current evidence of success in VBC, why VBC is still underhyped, barriers for Medicaid models, and more. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>33</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ac8480ac-1339-4bf6-9d48-aba27ac9e295</guid>
      <title>Ep 32: Heather Fernandez (Solv CEO) on Reinventing Last-Minute Care</title>
      <description><![CDATA[<p>Jacob and Nikhil speak with Heather Fernandez, CEO and Co-Founder of Solv, a company that focuses on getting people access to high-quality, last-minute care. Heather discusses the future of urgent care, operating a digital health company during Covid, crafting a strong go-to-market strategy, the role of private equity in urgent care, and more.</p><p> </p><p>(0:00) intro</p><p>(3:07) what is Solv?</p><p>(10:50) why is scheduling so bad in healthcare?</p><p>(16:03) is urgent care a net good?</p><p>(20:35) areas where urgent care can improve</p><p>(24:07) will urgent and longitudinal care combine somehow?</p><p>(25:31) Solv during Covid</p><p>(32:54) state by state healthcare nuances</p><p>(39:16) private equity and urgent care</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></description>
      <pubDate>Tue, 17 Oct 2023 15:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Heather Fernandez, Nikhil Krishnan, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-32-heather-fernandez-solv-ceo-on-reinventing-last-minute-care-LhLqbdBG</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil speak with Heather Fernandez, CEO and Co-Founder of Solv, a company that focuses on getting people access to high-quality, last-minute care. Heather discusses the future of urgent care, operating a digital health company during Covid, crafting a strong go-to-market strategy, the role of private equity in urgent care, and more.</p><p> </p><p>(0:00) intro</p><p>(3:07) what is Solv?</p><p>(10:50) why is scheduling so bad in healthcare?</p><p>(16:03) is urgent care a net good?</p><p>(20:35) areas where urgent care can improve</p><p>(24:07) will urgent and longitudinal care combine somehow?</p><p>(25:31) Solv during Covid</p><p>(32:54) state by state healthcare nuances</p><p>(39:16) private equity and urgent care</p><p> </p><p>Out-Of-Pocket: https://www.outofpocket.health/</p>
]]></content:encoded>
      <enclosure length="40232377" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/44b1f013-15d6-42ad-b7f9-d43333ebc33f/audio/9228b2c1-7895-4d64-9a01-9fd06a22e0cd/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 32: Heather Fernandez (Solv CEO) on Reinventing Last-Minute Care</itunes:title>
      <itunes:author>Heather Fernandez, Nikhil Krishnan, Jacob Effron</itunes:author>
      <itunes:duration>00:41:54</itunes:duration>
      <itunes:summary>Jacob and Nikhil speak with Heather Fernandez, CEO and Co-Founder of Solv, a company that focuses on getting people access to high-quality, last-minute care. Heather discusses the future of urgent care, operating a digital health company during Covid, crafting a strong go-to-market strategy, the role of private equity in urgent care, and more.</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil speak with Heather Fernandez, CEO and Co-Founder of Solv, a company that focuses on getting people access to high-quality, last-minute care. Heather discusses the future of urgent care, operating a digital health company during Covid, crafting a strong go-to-market strategy, the role of private equity in urgent care, and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>32</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e13d444b-dfc3-4e6f-b10f-9a9a161669c4</guid>
      <title>Ep 31: Mark Cuban on Disrupting PBMs, Staying Curious &amp; Using AI to Avoid NBA Fines</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Mark Cuban to discuss his pharmaceutical startup, The Mark Cuban Cost Plus Drug Company. They discuss why Mark entered the healthcare industry, competing on price, staying curious, and the future of AI.</p><p> </p><p>(0:00) intro </p><p>(1:05) Mark’s journey into healthcare </p><p>(3:57) how the Mark Cuban Cost Plus Drug Company works </p><p>(7:51) B2B angle and disrupting PBMs</p><p>(12:51) getting into biologics and biosimilars </p><p>(24:46) manufacturing drugs </p><p>(27:11) how much of a role can technology play in healthcare? </p><p>(33:06) why Mark doesn’t put his name on buildings </p><p>(35:35) over-hyped/under-hyped </p><p>(40:08) policy changes that could improve healthcare </p><p>(41:17) Mark’s best cameo</p>
]]></description>
      <pubDate>Wed, 4 Oct 2023 17:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Mark Cuban, Jacob Effron, Nikhil Krishnan)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-31-mark-cuban-on-disrupting-pbms-staying-curious-using-ai-to-avoid-nba-fines-6wsvKJX3</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Mark Cuban to discuss his pharmaceutical startup, The Mark Cuban Cost Plus Drug Company. They discuss why Mark entered the healthcare industry, competing on price, staying curious, and the future of AI.</p><p> </p><p>(0:00) intro </p><p>(1:05) Mark’s journey into healthcare </p><p>(3:57) how the Mark Cuban Cost Plus Drug Company works </p><p>(7:51) B2B angle and disrupting PBMs</p><p>(12:51) getting into biologics and biosimilars </p><p>(24:46) manufacturing drugs </p><p>(27:11) how much of a role can technology play in healthcare? </p><p>(33:06) why Mark doesn’t put his name on buildings </p><p>(35:35) over-hyped/under-hyped </p><p>(40:08) policy changes that could improve healthcare </p><p>(41:17) Mark’s best cameo</p>
]]></content:encoded>
      <enclosure length="41795126" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/01bb0b1b-8714-4b8f-9981-cf126a7ca9b9/audio/885b3970-9110-464a-8d76-5d37848a389d/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 31: Mark Cuban on Disrupting PBMs, Staying Curious &amp; Using AI to Avoid NBA Fines</itunes:title>
      <itunes:author>Mark Cuban, Jacob Effron, Nikhil Krishnan</itunes:author>
      <itunes:duration>00:43:32</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Mark Cuban to discuss his pharmaceutical startup, The Mark Cuban Cost Plus Drug Company. They discuss why Mark entered the healthcare industry, competing on price, staying curious, and the future of AI. </itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Mark Cuban to discuss his pharmaceutical startup, The Mark Cuban Cost Plus Drug Company. They discuss why Mark entered the healthcare industry, competing on price, staying curious, and the future of AI. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>31</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a606f372-75fe-4f39-8f94-68b05976a8a7</guid>
      <title>Ep 30: Marley Medical CEO Chris Hogg on Which Health Tech GTM Models Are Best and Using AI in Care</title>
      <description><![CDATA[<p>Jacob sits down with Marley Medical CEO Chris Hogg to discuss how he and his team select markets, think about go-to-market and utilize AI. Chris also reflects on his learnings from Propeller and more.</p><p> </p><p>0:00 intro</p><p>1:08 digital health over the last decade</p><p>3:01 100Plus</p><p>5:45 Propeller and fitting into patients’ daily lives</p><p>12:37 is the B2B2C model flawed?</p><p>17:01 Marley Medical</p><p>19:32 selecting markets</p><p>28:23 standing out from the competition</p><p>30:23 how is Marley using AI?</p><p>36:57 over-hyped/under-hyped</p>
]]></description>
      <pubDate>Thu, 21 Sep 2023 16:04:08 +0000</pubDate>
      <author>jeffron@redpoint.com (Chris Hogg, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-30-marley-medical-ceo-chris-hogg-on-which-health-tech-gtm-models-are-best-and-using-ai-in-care-cbTRsOSk</link>
      <content:encoded><![CDATA[<p>Jacob sits down with Marley Medical CEO Chris Hogg to discuss how he and his team select markets, think about go-to-market and utilize AI. Chris also reflects on his learnings from Propeller and more.</p><p> </p><p>0:00 intro</p><p>1:08 digital health over the last decade</p><p>3:01 100Plus</p><p>5:45 Propeller and fitting into patients’ daily lives</p><p>12:37 is the B2B2C model flawed?</p><p>17:01 Marley Medical</p><p>19:32 selecting markets</p><p>28:23 standing out from the competition</p><p>30:23 how is Marley using AI?</p><p>36:57 over-hyped/under-hyped</p>
]]></content:encoded>
      <enclosure length="44338048" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/377ea81c-57bb-4c96-b515-f83e09a8b92c/audio/233ac9b5-8189-4278-9463-2e70eb116698/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 30: Marley Medical CEO Chris Hogg on Which Health Tech GTM Models Are Best and Using AI in Care</itunes:title>
      <itunes:author>Chris Hogg, Jacob Effron</itunes:author>
      <itunes:duration>00:46:11</itunes:duration>
      <itunes:summary>Jacob sits down with Marley Medical CEO Chris Hogg to discuss how he and his team select markets, think about go-to-market and utilize AI. Chris also reflects on his learnings from Propeller and more.</itunes:summary>
      <itunes:subtitle>Jacob sits down with Marley Medical CEO Chris Hogg to discuss how he and his team select markets, think about go-to-market and utilize AI. Chris also reflects on his learnings from Propeller and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>30</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">edd5033e-b0a3-4e69-809b-0619d86be534</guid>
      <title>Ep 29: Omada Health CEO Sean Duffy on Evolving Employer Pricing, Incorporating GLP-1s and Using LLMs</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Sean Duffy, the CEO of health tech unicorn Omada Health, to discuss how Omada is using Large Language Models and incorporating GLP-1s into its care. They also hit on how Omada has thought and evolved its employer pricing.<br /> </p><p>0:00 intro</p><p>0:43 starting Omada Health</p><p>5:14 how Omada differs from Sean’s original vision</p><p>8:58 evolving employer pricing</p><p>16:31 how the care model has changed over time </p><p>19:25 GLP-1s</p><p>27:14 how Omada has incorporated AI</p><p>36:12 Livongo-Teladoc merger</p><p>40:20 coining the term “digital therapeutics”</p><p>43:14 over-hyped/under-hyped</p><p>44:47 policy changes that could improve healthcare</p>
]]></description>
      <pubDate>Tue, 15 Aug 2023 16:07:15 +0000</pubDate>
      <author>jeffron@redpoint.com (Sean Duffy, Jacob Effron, Nikhil Krishnan)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-29-omada-health-ceo-sean-duffy-on-evolving-employer-pricing-incorporating-glp-1s-and-using-llms-v5zi3wij</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Sean Duffy, the CEO of health tech unicorn Omada Health, to discuss how Omada is using Large Language Models and incorporating GLP-1s into its care. They also hit on how Omada has thought and evolved its employer pricing.<br /> </p><p>0:00 intro</p><p>0:43 starting Omada Health</p><p>5:14 how Omada differs from Sean’s original vision</p><p>8:58 evolving employer pricing</p><p>16:31 how the care model has changed over time </p><p>19:25 GLP-1s</p><p>27:14 how Omada has incorporated AI</p><p>36:12 Livongo-Teladoc merger</p><p>40:20 coining the term “digital therapeutics”</p><p>43:14 over-hyped/under-hyped</p><p>44:47 policy changes that could improve healthcare</p>
]]></content:encoded>
      <enclosure length="46090551" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/df493fb9-4ece-43e2-96ce-3ea76a6dff73/audio/35528b8e-ce66-4fab-bfeb-8840eed9aaf5/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 29: Omada Health CEO Sean Duffy on Evolving Employer Pricing, Incorporating GLP-1s and Using LLMs</itunes:title>
      <itunes:author>Sean Duffy, Jacob Effron, Nikhil Krishnan</itunes:author>
      <itunes:duration>00:48:00</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Sean Duffy, the CEO of health tech unicorn Omada Health, to discuss how Omada is using Large Language Models and incorporating GLP-1s into its care. They also hit on how Omada has thought and evolved its employer pricing.
</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Sean Duffy, the CEO of health tech unicorn Omada Health, to discuss how Omada is using Large Language Models and incorporating GLP-1s into its care. They also hit on how Omada has thought and evolved its employer pricing.
</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>29</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ecf1efe6-2d42-4bd6-9268-02f8616e96bb</guid>
      <title>Ep 27: PathAI CEO Dr. Andy Beck on the Future of AI in Medical Diagnosis</title>
      <description><![CDATA[<p>Jacob sits down with PathAI Ceo Dr. Andy Beck to discuss the state of AI adoption in diagnosis, why Path acquired their own lab, pathologists' jobs in the future and nailing GTM to reach a ~$1B valuation. </p><p> </p><p>00:00 intro </p><p>01:01 pathology and AI </p><p>13:30 nailing go-to-market strategy </p><p>19:47 how pathology labs can go digital </p><p>25:36 regulatory frameworks and roadblocks </p><p>33:05 do improvements in foundation models impact PathAI? </p><p>36:26 standardizing diagnoses </p><p>40:05 how will the job of a pathologist change going forward? </p><p>42:35 NASH </p><p>47:30 working in Daphne Koller’s lab</p>
]]></description>
      <pubDate>Tue, 25 Jul 2023 16:55:40 +0000</pubDate>
      <author>jeffron@redpoint.com (Andy Beck, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-27-pathai-ceo-dr-andy-beck-on-the-future-of-ai-in-medical-diagnoses-0ueH1DLh</link>
      <content:encoded><![CDATA[<p>Jacob sits down with PathAI Ceo Dr. Andy Beck to discuss the state of AI adoption in diagnosis, why Path acquired their own lab, pathologists' jobs in the future and nailing GTM to reach a ~$1B valuation. </p><p> </p><p>00:00 intro </p><p>01:01 pathology and AI </p><p>13:30 nailing go-to-market strategy </p><p>19:47 how pathology labs can go digital </p><p>25:36 regulatory frameworks and roadblocks </p><p>33:05 do improvements in foundation models impact PathAI? </p><p>36:26 standardizing diagnoses </p><p>40:05 how will the job of a pathologist change going forward? </p><p>42:35 NASH </p><p>47:30 working in Daphne Koller’s lab</p>
]]></content:encoded>
      <enclosure length="48595371" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/d9add984-74d7-471d-81a8-e1ba754bb58b/audio/4ea96732-5350-4468-be04-b82d278b48f7/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 27: PathAI CEO Dr. Andy Beck on the Future of AI in Medical Diagnosis</itunes:title>
      <itunes:author>Andy Beck, Jacob Effron</itunes:author>
      <itunes:duration>00:50:37</itunes:duration>
      <itunes:summary>Jacob sits down with PathAI Ceo Dr. Andy Beck to discuss the state of AI adoption in diagnosis, why Path acquired their own lab, pathologists&apos; jobs in the future and nailing GTM to reach a ~$1B valuation. </itunes:summary>
      <itunes:subtitle>Jacob sits down with PathAI Ceo Dr. Andy Beck to discuss the state of AI adoption in diagnosis, why Path acquired their own lab, pathologists&apos; jobs in the future and nailing GTM to reach a ~$1B valuation. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>27</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4bef752c-cd3a-441d-b65e-dfd0f392d8f3</guid>
      <title>Ep 26: Dr. Austin Chiang on Using Social Media to Educate His &gt;500K Followers and GLP-1s</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Dr. Austin Chiang, an interventional GI doc and Chief Medical Officer of Medtronic’s GI business who also has >500K TikTok Followers. We discuss how social media companies deal with public health issues, how doctors can use social media, lessons from being a “physician influencer,” the consumerization of GLP-1s and more.</p><p> </p><p>0:00 intro</p><p>1:02 how Austin got into medicine and social media</p><p>4:59 highlights and lowlights of being a recognizable figure in the medical world</p><p>8:47 balancing engagement with education</p><p>25:22 how to steer away from misinformation</p><p>30:51 the consumerization of GLP-1s</p><p>39:24 tips for doctors on social media</p><p>45:45 how to market to physicians</p><p>47:31 public health campaigns on social media </p><p>52:10 Austin’s favorite post</p>
]]></description>
      <pubDate>Tue, 11 Jul 2023 13:51:12 +0000</pubDate>
      <author>jeffron@redpoint.com (Austin Chiang, Nikhil Krishnan, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-26-dr-austin-chiang-on-using-social-media-to-educate-his-500k-followers-and-glp-1s-1BMo5yr3</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Dr. Austin Chiang, an interventional GI doc and Chief Medical Officer of Medtronic’s GI business who also has >500K TikTok Followers. We discuss how social media companies deal with public health issues, how doctors can use social media, lessons from being a “physician influencer,” the consumerization of GLP-1s and more.</p><p> </p><p>0:00 intro</p><p>1:02 how Austin got into medicine and social media</p><p>4:59 highlights and lowlights of being a recognizable figure in the medical world</p><p>8:47 balancing engagement with education</p><p>25:22 how to steer away from misinformation</p><p>30:51 the consumerization of GLP-1s</p><p>39:24 tips for doctors on social media</p><p>45:45 how to market to physicians</p><p>47:31 public health campaigns on social media </p><p>52:10 Austin’s favorite post</p>
]]></content:encoded>
      <enclosure length="54109934" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/a2ac716f-6062-4c36-b218-757ef8e08462/audio/62472399-4f7a-4dc5-a8e3-cfdcfc3533de/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 26: Dr. Austin Chiang on Using Social Media to Educate His &gt;500K Followers and GLP-1s</itunes:title>
      <itunes:author>Austin Chiang, Nikhil Krishnan, Jacob Effron</itunes:author>
      <itunes:duration>00:56:21</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Dr. Austin Chiang, an interventional GI doc and Chief Medical Officer of Medtronic’s GI business who also has &gt;500K TikTok Followers. We discuss how social media companies deal with public health issues, how doctors can use social media, lessons from being a “physician influencer,” the consumerization of GLP-1s and more.</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Dr. Austin Chiang, an interventional GI doc and Chief Medical Officer of Medtronic’s GI business who also has &gt;500K TikTok Followers. We discuss how social media companies deal with public health issues, how doctors can use social media, lessons from being a “physician influencer,” the consumerization of GLP-1s and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>26</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">dd751a68-b34b-4d6b-9458-618237574204</guid>
      <title>Ep 25: Dotmatics CEO Thomas Swalla on The State of R&amp;D Software</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Dotmatics CEO Thomas Swalla to discuss R&D software, differences in software requirements across biotechs, growing through 11 acquisitions and expanding beyond life sciences. </p><p> </p><p>0:00 intro</p><p>0:36 getting into healthcare</p><p>5:20 what R&D looks like today</p><p>8:03 what does Dotmatics do?</p><p>13:06 differences in software requirements across biotechs</p><p>20:15 bundling vs. “best-of-breed”</p><p>23:46 do life sciences need their own data tools?</p><p>26:44 incorporating AI into Dotmatics tools</p><p>34:38 AI replacing scientists</p><p>37:39 how Dotmatics tools can serve companies outside of life sciences</p><p>39:50 acquisition strategy</p><p>44:43 spaces for innovation in R&D</p>
]]></description>
      <pubDate>Tue, 27 Jun 2023 13:52:38 +0000</pubDate>
      <author>jeffron@redpoint.com (Thomas Swalla, Nikhil Krishnan, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-25-dotmatics-ceo-thomas-swalla-on-the-state-of-rd-software-_3MMfwKa</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Dotmatics CEO Thomas Swalla to discuss R&D software, differences in software requirements across biotechs, growing through 11 acquisitions and expanding beyond life sciences. </p><p> </p><p>0:00 intro</p><p>0:36 getting into healthcare</p><p>5:20 what R&D looks like today</p><p>8:03 what does Dotmatics do?</p><p>13:06 differences in software requirements across biotechs</p><p>20:15 bundling vs. “best-of-breed”</p><p>23:46 do life sciences need their own data tools?</p><p>26:44 incorporating AI into Dotmatics tools</p><p>34:38 AI replacing scientists</p><p>37:39 how Dotmatics tools can serve companies outside of life sciences</p><p>39:50 acquisition strategy</p><p>44:43 spaces for innovation in R&D</p>
]]></content:encoded>
      <enclosure length="46724187" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/3d97e6b5-1f1f-4c89-bae1-7746544730d5/audio/0eee55f0-8ed2-4ade-a963-e4d0a95df1eb/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 25: Dotmatics CEO Thomas Swalla on The State of R&amp;D Software</itunes:title>
      <itunes:author>Thomas Swalla, Nikhil Krishnan, Jacob Effron</itunes:author>
      <itunes:duration>00:48:40</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Dotmatics CEO Thomas Swalla to discuss R&amp;D software, differences in software requirements across biotechs, growing through 11 acquisitions and expanding beyond life sciences.</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Dotmatics CEO Thomas Swalla to discuss R&amp;D software, differences in software requirements across biotechs, growing through 11 acquisitions and expanding beyond life sciences.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>25</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">16cae948-49c2-4870-a6a5-be02ddef66cb</guid>
      <title>Ep 24: Insitro CEO Daphne Koller on Using ML to Change Drug Discovery</title>
      <description><![CDATA[<p>Jacob sits down with Insitro CEO Daphne Koller to discuss founding Coursera, where and how ML can drive the most impact in drug development, and if foundation models can transform core drug discovery work and edtech.</p><p> </p><p>00:00 intro</p><p>00:59 Daphne’s journey</p><p>09:02 AI and biology discovery</p><p>10:42 insitro vs. traditional pharma</p><p>19:47 phenotyping patients</p><p>25:44 early mistakes</p><p>29:34 the future of data</p><p>35:16 partnering with larger pharma companies</p><p>38:00 impact of LLMs on biopharma</p><p>43:47 over-hyped/under-hyped</p>
]]></description>
      <pubDate>Tue, 13 Jun 2023 16:44:29 +0000</pubDate>
      <author>jeffron@redpoint.com (Daphne Koller, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-24-insitro-ceo-daphne-koller-on-using-ml-to-change-drug-discovery-h4fq00oX</link>
      <content:encoded><![CDATA[<p>Jacob sits down with Insitro CEO Daphne Koller to discuss founding Coursera, where and how ML can drive the most impact in drug development, and if foundation models can transform core drug discovery work and edtech.</p><p> </p><p>00:00 intro</p><p>00:59 Daphne’s journey</p><p>09:02 AI and biology discovery</p><p>10:42 insitro vs. traditional pharma</p><p>19:47 phenotyping patients</p><p>25:44 early mistakes</p><p>29:34 the future of data</p><p>35:16 partnering with larger pharma companies</p><p>38:00 impact of LLMs on biopharma</p><p>43:47 over-hyped/under-hyped</p>
]]></content:encoded>
      <enclosure length="46884253" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/9179c84e-3980-4bf5-b9c9-7e5939a1e8d0/audio/ddd496e2-231b-441c-affa-a428c592a802/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 24: Insitro CEO Daphne Koller on Using ML to Change Drug Discovery</itunes:title>
      <itunes:author>Daphne Koller, Jacob Effron</itunes:author>
      <itunes:duration>00:48:50</itunes:duration>
      <itunes:summary>Jacob sits down with Insitro CEO Daphne Koller to discuss founding Coursera, where and how ML can drive the most impact in drug development, and if foundation models can transform core drug discovery work and edtech.</itunes:summary>
      <itunes:subtitle>Jacob sits down with Insitro CEO Daphne Koller to discuss founding Coursera, where and how ML can drive the most impact in drug development, and if foundation models can transform core drug discovery work and edtech.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>24</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d25a6ca1-2258-4e8d-a79c-aa3658749303</guid>
      <title>Ep 23: Stanford Professor James Zou on the Economics, Regulation and Applications of AI in Healthcare</title>
      <description><![CDATA[<p>00:00 intro</p><p>01:08 James’ background</p><p>04:39 regulation of AI medical devices</p><p>14:43 impact of foundation models on healthcare</p><p>19:41 the future of cancer detection</p><p>23:47 real-world control arms</p><p>35:18 AI drift</p><p>37:42 over-hyped/under-hyped</p><p>40:03 most surprising AI interaction </p>
]]></description>
      <pubDate>Fri, 26 May 2023 15:32:09 +0000</pubDate>
      <author>jeffron@redpoint.com (Nikhil Krishnan, James Zou, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-23-stanford-professor-james-zou-on-the-economics-regulation-and-applications-of-ai-in-healthcare-x7yoPm9U</link>
      <content:encoded><![CDATA[<p>00:00 intro</p><p>01:08 James’ background</p><p>04:39 regulation of AI medical devices</p><p>14:43 impact of foundation models on healthcare</p><p>19:41 the future of cancer detection</p><p>23:47 real-world control arms</p><p>35:18 AI drift</p><p>37:42 over-hyped/under-hyped</p><p>40:03 most surprising AI interaction </p>
]]></content:encoded>
      <enclosure length="41298209" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/9ba00019-60cf-4b04-8e2c-8bb0f0a3d4af/audio/94ec6775-b16b-487c-8610-e0fed33020ac/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 23: Stanford Professor James Zou on the Economics, Regulation and Applications of AI in Healthcare</itunes:title>
      <itunes:author>Nikhil Krishnan, James Zou, Jacob Effron</itunes:author>
      <itunes:duration>00:43:01</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with James Zou, Stanford faculty director of Data4Health and widely cited ML paper author and discuss all things AI including early cancer detection, clinical trials, clinician adoption, FDA regulation and the impact of foundation models.</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with James Zou, Stanford faculty director of Data4Health and widely cited ML paper author and discuss all things AI including early cancer detection, clinical trials, clinician adoption, FDA regulation and the impact of foundation models.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>23</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a0fe3f56-cc9b-496c-8e5e-98e52126e7f3</guid>
      <title>Ep 22: Dr. Ezekiel Emanuel on Our Relationship with Death and Bad Incentives in Research</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Dr. Ezekiel Emanuel and discuss his reflections on his “Why I want to Die at 75” piece, how publishing/financial incentives harm research, doctors' increasing social isolation and his love of chocolate-making.</p>
]]></description>
      <pubDate>Tue, 9 May 2023 13:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-22-dr-ezekiel-emanuel-on-our-relationship-with-death-and-bad-incentives-in-research-cbX3V4Yb</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Dr. Ezekiel Emanuel and discuss his reflections on his “Why I want to Die at 75” piece, how publishing/financial incentives harm research, doctors' increasing social isolation and his love of chocolate-making.</p>
]]></content:encoded>
      <enclosure length="47095266" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/97cbe778-7741-4db1-b142-526b74706ea6/audio/32dbc422-1b8f-438b-9693-580b1f6f4f47/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 22: Dr. Ezekiel Emanuel on Our Relationship with Death and Bad Incentives in Research</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:49:03</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Dr. Ezekiel Emanuel and discuss his reflections on his “Why I want to Die at 75” piece, how publishing/financial incentives harm research, doctors&apos; increasing social isolation and his love of chocolate-making.</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Dr. Ezekiel Emanuel and discuss his reflections on his “Why I want to Die at 75” piece, how publishing/financial incentives harm research, doctors&apos; increasing social isolation and his love of chocolate-making.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>22</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ee21676b-dd7b-4825-bfac-5d78cdfb464a</guid>
      <title>Ep 21: Andy Coravos and Ashoka Rajendra on Hyperspecialization in Pharma R&amp;D and Digital Biomarkers</title>
      <description><![CDATA[Jacob sits down with HumanFirst CEO Andy Coravos and Orchestra CEO Ashoka Rajendra to discuss at home data collection in trials, Andy being an EIR at the FDA, why Benchling has been so successful and more. 
]]></description>
      <pubDate>Tue, 25 Apr 2023 13:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-21-andy-coravos-and-ashoka-rajendra-on-hyperspecialization-in-pharma-rd-and-digital-biomarkers-qZEIe7dW</link>
      <enclosure length="40685862" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/eeae0ee7-7cbc-46ab-8c66-3c89f55bacb4/audio/1c2c427b-4c00-4082-a5ac-1cd42939ae52/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 21: Andy Coravos and Ashoka Rajendra on Hyperspecialization in Pharma R&amp;D and Digital Biomarkers</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:42:22</itunes:duration>
      <itunes:summary>Jacob sits down with HumanFirst CEO Andy Coravos and Orchestra CEO Ashoka Rajendra to discuss at home data collection in trials, Andy being an EIR at the FDA, why Benchling has been so successful and more.</itunes:summary>
      <itunes:subtitle>Jacob sits down with HumanFirst CEO Andy Coravos and Orchestra CEO Ashoka Rajendra to discuss at home data collection in trials, Andy being an EIR at the FDA, why Benchling has been so successful and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>21</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">bc30efd3-da25-4dd4-866a-b422047d94dc</guid>
      <title>Ep 20: Andy Slavitt on Optum’s Evolution and Lessons from Obamacare and COVID</title>
      <description><![CDATA[<p>Andy Slavitt, former Optum EVP, head of CMS, COVID advisor and <a href="http://healthcare.gov/" target="_blank">healthcare.gov</a> saver joins Nikhil and Jacob to discuss public/private sector collaboration, Optum’s evolution, and his lessons on communication from COVID. Andy also shared his career journey, what he would do if he was running United today and how the private sector can work better with the public sector.</p>
]]></description>
      <pubDate>Tue, 11 Apr 2023 13:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-20-andy-slavitt-on-optums-evolution-and-lessons-from-obamacare-and-covid-_Pjlsgg5</link>
      <content:encoded><![CDATA[<p>Andy Slavitt, former Optum EVP, head of CMS, COVID advisor and <a href="http://healthcare.gov/" target="_blank">healthcare.gov</a> saver joins Nikhil and Jacob to discuss public/private sector collaboration, Optum’s evolution, and his lessons on communication from COVID. Andy also shared his career journey, what he would do if he was running United today and how the private sector can work better with the public sector.</p>
]]></content:encoded>
      <enclosure length="45377872" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/b7f03f39-20c1-4ef9-91db-7856cdba335f/audio/56a8a286-1934-4e30-9857-be8cd68186b5/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 20: Andy Slavitt on Optum’s Evolution and Lessons from Obamacare and COVID</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:47:16</itunes:duration>
      <itunes:summary>Andy Slavitt, former Optum EVP, head of CMS, COVID advisor and healthcare.gov saver joins Nikhil and Jacob to discuss public/private sector collaboration, Optum’s evolution, and his lessons on communication from COVID. Andy also shared his career journey, what he would do if he was running United today and how the private sector can work better with the public sector.
With your hosts:
@jacobeffron
-Partner at Redpoint, Former PM Flatiron Health
Nikhil Krishnan @nikillinit
-Founder, Out-Of-Pocket: outofpocket.health</itunes:summary>
      <itunes:subtitle>Andy Slavitt, former Optum EVP, head of CMS, COVID advisor and healthcare.gov saver joins Nikhil and Jacob to discuss public/private sector collaboration, Optum’s evolution, and his lessons on communication from COVID. Andy also shared his career journey, what he would do if he was running United today and how the private sector can work better with the public sector.
With your hosts:
@jacobeffron
-Partner at Redpoint, Former PM Flatiron Health
Nikhil Krishnan @nikillinit
-Founder, Out-Of-Pocket: outofpocket.health</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>20</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a97923ee-139b-4862-a4c2-7661b05a6345</guid>
      <title>Ep 19: Mike Kopko on ACO Reach and The Future of Health Exchanges</title>
      <description><![CDATA[<p>Jacob and Nikhil sit down with Mike Kopko, CEO and co-founder of Pearl Health to discuss Pearl’s care model and what it’s been like building the company as ACO Reach evolved. Mike also shares some great stories negotiating claims in the early days of Oscar.</p>
]]></description>
      <pubDate>Tue, 28 Mar 2023 13:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-19-mike-kopko-on-aco-reach-and-the-future-of-health-exchanges-jcVfA_kN</link>
      <content:encoded><![CDATA[<p>Jacob and Nikhil sit down with Mike Kopko, CEO and co-founder of Pearl Health to discuss Pearl’s care model and what it’s been like building the company as ACO Reach evolved. Mike also shares some great stories negotiating claims in the early days of Oscar.</p>
]]></content:encoded>
      <enclosure length="36209519" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/43f5ef7c-6a98-4488-a8fb-a44dafa2706e/audio/5e56be29-3b44-44bd-bbbc-8b6493e623cb/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 19: Mike Kopko on ACO Reach and The Future of Health Exchanges</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:37:43</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Mike Kopko, CEO and co-founder of Pearl Health to discuss Pearl’s care model and what it’s been like building the company as ACO Reach evolved. Mike also shares some great stories negotiating claims in the early days of Oscar.</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Mike Kopko, CEO and co-founder of Pearl Health to discuss Pearl’s care model and what it’s been like building the company as ACO Reach evolved. Mike also shares some great stories negotiating claims in the early days of Oscar.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>19</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4b6cf7a2-cd8b-4592-8354-336de0d69ec0</guid>
      <title>Ep 18: Dr. Jeffrey Kang on CVS/Walgreens&apos; Role in Healthcare and The Future of Risk Adjustment and Senior Care</title>
      <description><![CDATA[Jacob and Nikhil sit down with Dr. Jeffrey Kang, CEO of WellBe Senior Medical, and former President of ChenMed, SVP Health and Wellness Solutions at Walgreens, CMO at Cigna, CMO at CMS and CEO of Urban Medical Group. They discuss risk adjustment, retailers in healthcare and how healthcare has/hasn't changed since his work doing risk-based care for complex patients and at CMS in the 80s and 90s.   
]]></description>
      <pubDate>Thu, 16 Mar 2023 13:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-18-dr-jeffrey-kang-on-cvs-walgreens-role-in-healthcare-and-the-future-of-risk-adjustment-and-senior-care-NS1BoWKT</link>
      <enclosure length="37625983" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/ad57917c-5d66-4b10-887f-895d5f1e3562/audio/01815058-a3fe-46c1-8e74-438a74a3ba63/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 18: Dr. Jeffrey Kang on CVS/Walgreens&apos; Role in Healthcare and The Future of Risk Adjustment and Senior Care</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:39:11</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Dr. Jeffrey Kang, CEO of WellBe Senior Medical, and former President of ChenMed, SVP Health and Wellness Solutions at Walgreens, CMO at Cigna, CMO at CMS and CEO of Urban Medical Group. They discuss risk adjustment, retailers in healthcare and how healthcare has/hasn&apos;t changed since his work doing risk-based care for complex patients and at CMS in the 80s and 90s.  </itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Dr. Jeffrey Kang, CEO of WellBe Senior Medical, and former President of ChenMed, SVP Health and Wellness Solutions at Walgreens, CMO at Cigna, CMO at CMS and CEO of Urban Medical Group. They discuss risk adjustment, retailers in healthcare and how healthcare has/hasn&apos;t changed since his work doing risk-based care for complex patients and at CMS in the 80s and 90s.  </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>18</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a24d5f59-4ce5-4c21-9c73-363fa6d01e2a</guid>
      <title>Ep 17: Naomi Allen on How to Sell to Employers and the Future of Mental Healthcare</title>
      <description><![CDATA[Jacob and Nikhil sit down with Naomi Allen, CEO and founder of Brightline (child and teen focused mental health company that’s raised >$100M) and Castlight/Livongo exec. They discuss the difficulties of balancing employer customers and employee satisfaction at Castlight, how Livongo captured member delight and Brightline's care model.  
]]></description>
      <pubDate>Wed, 1 Mar 2023 14:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-17-Zmxu7XRb</link>
      <enclosure length="47165066" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/a1b3ff72-6856-4ee2-bee6-d33201ec21db/audio/c6ad030a-566d-4569-9b51-25e6a6948733/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 17: Naomi Allen on How to Sell to Employers and the Future of Mental Healthcare</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:49:07</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Naomi Allen, CEO and founder of Brightline (child and teen focused mental health company that’s raised &gt;$100M) and Castlight/Livongo exec. They discuss the difficulties of balancing employer customers and employee satisfaction at Castlight, how Livongo captured member delight and Brightline&apos;s care model. </itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Naomi Allen, CEO and founder of Brightline (child and teen focused mental health company that’s raised &gt;$100M) and Castlight/Livongo exec. They discuss the difficulties of balancing employer customers and employee satisfaction at Castlight, how Livongo captured member delight and Brightline&apos;s care model. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>17</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">95217f0f-9977-42ec-92e9-b3a1c0bb74ff</guid>
      <title>Ep 16: Dr. Jaewon Ryu on Geisinger&apos;s Fresh Food and DNA Sequencing Programs and the Future of Clinician Training</title>
      <description><![CDATA[Jacob sits down with Geisinger CEO Dr. Jaewon Ryu to discuss how he and Geisinger think about their Fresh Food Farmacy, population-wide DNA sequencing efforts, and transforming medical education. 
]]></description>
      <pubDate>Tue, 14 Feb 2023 14:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-16-dr-jaewon-ryu-on-geisingers-fresh-food-and-dna-sequencing-programs-and-the-future-of-clinician-training-kmO6LKQh</link>
      <enclosure length="37882192" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/5b8564da-a10f-4ec7-9f04-689fde4eb1f6/audio/ec2074ee-9b42-4c95-bbb4-e5529b3f7ea0/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 16: Dr. Jaewon Ryu on Geisinger&apos;s Fresh Food and DNA Sequencing Programs and the Future of Clinician Training</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:39:27</itunes:duration>
      <itunes:summary>Jacob sits down with Geisinger CEO Dr. Jaewon Ryu to discuss how he and Geisinger think about their Fresh Food Farmacy, population-wide DNA sequencing efforts, and transforming medical education.</itunes:summary>
      <itunes:subtitle>Jacob sits down with Geisinger CEO Dr. Jaewon Ryu to discuss how he and Geisinger think about their Fresh Food Farmacy, population-wide DNA sequencing efforts, and transforming medical education.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>16</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">96cdc7b8-7f0c-48a8-80d2-2bc0c5083a06</guid>
      <title>Ep 15: Dr. Jenny Schneider on What Livongo Got Right and Improving Rural Healthcare</title>
      <description><![CDATA[Jacob sits down with Homeward Health CEO and former Castlight and Livongo CMO Dr. Jenny Schneider to discuss solving provider shortages in rural markets, how tech can/can’t help care and what Livongo did to make coaching more effective. 
]]></description>
      <pubDate>Thu, 2 Feb 2023 14:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-15-dr-jenny-schneider-on-what-livongo-got-right-and-improving-rural-healthcare-Pq7R9p3v</link>
      <enclosure length="25656050" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/c28d368f-5db8-4b9b-94bd-eae8802aff39/audio/604c15c7-9aff-40a1-bc01-1b05f14f4f65/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 15: Dr. Jenny Schneider on What Livongo Got Right and Improving Rural Healthcare</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:26:43</itunes:duration>
      <itunes:summary>Jacob sits down with Homeward Health CEO and former Castlight and Livongo CMO Dr. Jenny Schneider to discuss solving provider shortages in rural markets, how tech can/can’t help care and what Livongo did to make coaching more effective.</itunes:summary>
      <itunes:subtitle>Jacob sits down with Homeward Health CEO and former Castlight and Livongo CMO Dr. Jenny Schneider to discuss solving provider shortages in rural markets, how tech can/can’t help care and what Livongo did to make coaching more effective.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>15</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">dc8876e2-6d8c-4f17-9036-1c431311947e</guid>
      <title>Ep 14: Vijay Kedar on Oscar Reflections and What&apos;s Required to Make At Home Care Work</title>
      <description><![CDATA[Jacob and Nikhil sit down with Tomorrow Health CEO and former Oscar Texas GM Vijay Kedar to discuss lessons he learned at Oscar, reflections on the ACA market, the nuances of operationalizing at home care and what Tomorrow is building.  
]]></description>
      <pubDate>Thu, 19 Jan 2023 14:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-14-vijay-kedar-on-oscar-reflections-and-whats-required-to-make-at-home-care-work-3l4gzAVj</link>
      <enclosure length="39390189" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/ad82f0bf-4bd9-4ab7-9713-9d3d2c2cb194/audio/23318728-8638-4947-9e8d-8aec5626d2d1/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 14: Vijay Kedar on Oscar Reflections and What&apos;s Required to Make At Home Care Work</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:41:01</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Tomorrow Health CEO and former Oscar Texas GM Vijay Kedar to discuss lessons he learned at Oscar, reflections on the ACA market, the nuances of operationalizing at home care and what Tomorrow is building. </itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Tomorrow Health CEO and former Oscar Texas GM Vijay Kedar to discuss lessons he learned at Oscar, reflections on the ACA market, the nuances of operationalizing at home care and what Tomorrow is building. </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>14</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">7929b9d3-becf-443a-bff7-cb40afbd0908</guid>
      <title>Ep. 13: Annual Predictions and Robin Shah and Dr. Bobby Green on Designing New Cancer Care Models and The Future of Oncology</title>
      <description><![CDATA[Jacob and Nikhil discuss annual health-tech predictions and are then joined by Thyme Care co-founders Robin Shah and Dr. Bobby Green to discuss the nuances of taking risk in oncology, lessons on selling to providers, and what they're building at Thyme Care. 
0:00-9:10 Jacob & Nikhil discussion
9:13-end Thyme Care founders interview with Robin Shah and Dr. Bobby Green

 
]]></description>
      <pubDate>Thu, 5 Jan 2023 14:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-13-annual-predictions-and-robin-shah-and-dr-bobby-green-on-designing-new-cancer-care-models-and-the-future-of-oncology-AVT1PHG_</link>
      <enclosure length="35492302" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/a2eb5355-84b3-4cf6-a824-cde206d2ab03/audio/291e9d61-7bce-4f6b-984a-4e932ee20e2b/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep. 13: Annual Predictions and Robin Shah and Dr. Bobby Green on Designing New Cancer Care Models and The Future of Oncology</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:36:58</itunes:duration>
      <itunes:summary>Jacob and Nikhil discuss annual health-tech predictions and are then joined by Thyme Care co-founders Robin Shah and Dr. Bobby Green to discuss the nuances of taking risk in oncology, lessons on selling to providers, and what they&apos;re building at Thyme Care. 
0:00-9:10 Jacob &amp; Nikhil discussion
9:13-end Thyme Care founders interview with Robin Shah and Dr. Bobby Green

</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil discuss annual health-tech predictions and are then joined by Thyme Care co-founders Robin Shah and Dr. Bobby Green to discuss the nuances of taking risk in oncology, lessons on selling to providers, and what they&apos;re building at Thyme Care. 
0:00-9:10 Jacob &amp; Nikhil discussion
9:13-end Thyme Care founders interview with Robin Shah and Dr. Bobby Green

</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>13</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">fa274561-9f29-4e5f-920c-b0d03e23e94a</guid>
      <title>Ep 12: Chris Gibson on Building a Platform Biotech and The Future of R&amp;D</title>
      <description><![CDATA[Jacob sits down with Chris Gibson, the co-founder and CEO of Recursion, to discuss how Recursion predicted drugs that would be effective for COVID, his take on different techbio business models, what pharma R&D will look like in 25 years and more. 
]]></description>
      <pubDate>Wed, 14 Dec 2022 14:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-12-chris-gibson-on-building-a-platform-biotech-and-the-future-of-rd-O2tzq39H</link>
      <enclosure length="37756804" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/513a3bd1-e8cf-4661-9370-6d4f158efbcc/audio/d3b15595-2278-4863-92fd-4bac69f0f82c/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 12: Chris Gibson on Building a Platform Biotech and The Future of R&amp;D</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:39:19</itunes:duration>
      <itunes:summary>Jacob sits down with Chris Gibson, the co-founder and CEO of Recursion, to discuss how Recursion predicted drugs that would be effective for COVID, his take on different techbio business models, what pharma R&amp;D will look like in 25 years and more.</itunes:summary>
      <itunes:subtitle>Jacob sits down with Chris Gibson, the co-founder and CEO of Recursion, to discuss how Recursion predicted drugs that would be effective for COVID, his take on different techbio business models, what pharma R&amp;D will look like in 25 years and more.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>12</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4dd144a9-516e-4d10-86a1-3f275588a0f2</guid>
      <title>Ep 11: Dr. Arif Nathoo on the Evolution and Future of Healthcare Data and Building a Vertical SaaS Platform</title>
      <description><![CDATA[Jacob sits down with Dr. Arif Nathoo, the CEO of Komodo Health (most recently valued at $3.3B) to discuss Komodo’s journey from a single app to a platform, why EHR data is overhyped and where healthcare data is headed. 
]]></description>
      <pubDate>Tue, 29 Nov 2022 14:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-11-dr-arif-nathoo-on-the-evolution-and-future-of-healthcare-data-and-building-a-vertical-saas-platform-8N5x8YA2</link>
      <enclosure length="39124785" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/7f3647fc-e614-422d-8da7-b695cf1048cb/audio/91064b0f-252c-4f55-b595-7c88af6febd5/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 11: Dr. Arif Nathoo on the Evolution and Future of Healthcare Data and Building a Vertical SaaS Platform</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:40:45</itunes:duration>
      <itunes:summary>Jacob sits down with Dr. Arif Nathoo, the CEO of Komodo Health (most recently valued at $3.3B) to discuss Komodo’s journey from a single app to a platform, why EHR data is overhyped and where healthcare data is headed.</itunes:summary>
      <itunes:subtitle>Jacob sits down with Dr. Arif Nathoo, the CEO of Komodo Health (most recently valued at $3.3B) to discuss Komodo’s journey from a single app to a platform, why EHR data is overhyped and where healthcare data is headed.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>11</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f24743c7-e7b6-4036-ae1b-f273192bbe73</guid>
      <title>Ep 10: Dr. Bob Kocher on the Future of Health Systems and Increasing Healthcare Productivity</title>
      <description><![CDATA[Jacob and Nikhil sat down with Dr. Bob Kocher, the Venrock partner who helped write the Affordable Care Act while in the Obama administration to discuss how health systems will increase productivity, what drives healthcare costs, and his reflections on the ACA. 
]]></description>
      <pubDate>Wed, 16 Nov 2022 14:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-10-bob-kocher-on-the-future-of-health-systems-and-increasing-healthcare-productivity-V4Ee3kXv</link>
      <enclosure length="47396197" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/39065947-a09d-483b-a7a4-392267090635/audio/9cf0323e-a2d8-458c-abce-6b5573e4814f/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 10: Dr. Bob Kocher on the Future of Health Systems and Increasing Healthcare Productivity</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:49:22</itunes:duration>
      <itunes:summary>Jacob and Nikhil sat down with Dr. Bob Kocher, the Venrock partner who helped write the Affordable Care Act while in the Obama administration to discuss how health systems will increase productivity, what drives healthcare costs, and his reflections on the ACA.</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sat down with Dr. Bob Kocher, the Venrock partner who helped write the Affordable Care Act while in the Obama administration to discuss how health systems will increase productivity, what drives healthcare costs, and his reflections on the ACA.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>10</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">bf8994a3-d8d0-4960-9dbe-92f1ed0b434b</guid>
      <title>Ep 9: Eren Bali on Using Tech to Lower Healthcare Costs and Carbon Health&apos;s Strategy</title>
      <description><![CDATA[Jacob and Nikhil sit down with Carbon Health CEO and founder Eren Bali to discuss Carbon Health's evolution, how he thinks about Carbon Health's tech, partnerships and expansion and what policy changes he thinks would improve healthcare. 
]]></description>
      <pubDate>Thu, 27 Oct 2022 13:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/eren-bali-on-using-tech-to-lower-healthcare-costs-and-carbons-strategy-mBzP7vA0</link>
      <enclosure length="50144279" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/4b01867e-c6ce-42e2-971e-bf4a44a6b3d1/audio/825fe7a0-ed0c-48f0-8b11-fa43b4adf472/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 9: Eren Bali on Using Tech to Lower Healthcare Costs and Carbon Health&apos;s Strategy</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:52:13</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Carbon Health CEO and founder Eren Bali to discuss Carbon Health&apos;s evolution, how he thinks about Carbon Health&apos;s tech, partnerships and expansion and what policy changes he thinks would improve healthcare.</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Carbon Health CEO and founder Eren Bali to discuss Carbon Health&apos;s evolution, how he thinks about Carbon Health&apos;s tech, partnerships and expansion and what policy changes he thinks would improve healthcare.</itunes:subtitle>
      <itunes:explicit>true</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>9</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">99651ed4-7ed4-4a77-aaf5-53ee2b8f5f65</guid>
      <title>Ep 8: Dr. Sachin Jain on Incubating Businesses and Why Health Systems Will Drive Value-Based Care</title>
      <description><![CDATA[Jacob and Nikhil sit down with Dr. Sachin Jain to discuss operating as a non-profit, competing in Medicare Advantage and when PE/VC backing doesn’t make sense. He also shared some hot takes on new people entering healthcare and the importance of health systems in driving the move to value-based care. 
 
]]></description>
      <pubDate>Tue, 11 Oct 2022 13:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-8-AbdYrwoC</link>
      <enclosure length="44092648" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/254ab3e4-3b66-4b82-90c3-15402735bf70/audio/5941ad22-ee72-4bff-980f-52b1c536f234/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 8: Dr. Sachin Jain on Incubating Businesses and Why Health Systems Will Drive Value-Based Care</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:45:55</itunes:duration>
      <itunes:summary>Jacob and Nikhil sit down with Dr. Sachin Jain to discuss operating as a non-profit, competing in Medicare Advantage and when PE/VC backing doesn’t make sense. He also shared some hot takes on new people entering healthcare and the importance of health systems in driving the move to value-based care. 
</itunes:summary>
      <itunes:subtitle>Jacob and Nikhil sit down with Dr. Sachin Jain to discuss operating as a non-profit, competing in Medicare Advantage and when PE/VC backing doesn’t make sense. He also shared some hot takes on new people entering healthcare and the importance of health systems in driving the move to value-based care. 
</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>8</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">42028b58-65b6-4cbb-a121-83469578585d</guid>
      <title>Ep 7: Seema Verma on Running CMS During COVID and Drug Pricing</title>
      <description><![CDATA[Jacob sits down with Seema Verma to talk about rapid policymaking during COVID, recent drug pricing legislation, her reflections on her time at CMS and what areas of tech she's most excited about.
 
]]></description>
      <pubDate>Tue, 27 Sep 2022 13:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/seema-verma-on-running-cms-during-covid-and-drug-pricing-ZhTAXM4z</link>
      <enclosure length="33504906" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/b2c1b755-4721-45ae-8374-b5191536d7ed/audio/cc04814e-6508-46ef-89b4-9f5186aacd19/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 7: Seema Verma on Running CMS During COVID and Drug Pricing</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:34:53</itunes:duration>
      <itunes:summary>Jacob sits down with Seema Verma to talk about rapid policymaking during COVID, recent drug pricing legislation, her reflections on her time at CMS and what areas of tech she&apos;s most excited about.
</itunes:summary>
      <itunes:subtitle>Jacob sits down with Seema Verma to talk about rapid policymaking during COVID, recent drug pricing legislation, her reflections on her time at CMS and what areas of tech she&apos;s most excited about.
</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>7</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">8efb26fe-c5b6-4550-b47b-52728429e82b</guid>
      <title>Ep 6: Nikhil Krishnan on Doctor Influencers and Healthcare Hot Takes</title>
      <description><![CDATA[Jacob sits down with Nikhil Krishnan, founder of Out of Pocket, to discuss his path to becoming a healthcare meme king and the community he's building to get more people into healthcare and make it easier to start health tech businesses. They also hit on Nikhil’s thoughts on physician payment, big tech in healthcare and more.   
]]></description>
      <pubDate>Tue, 13 Sep 2022 13:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-6-nikhil-krishnan-on-doctor-influencers-and-hot-healthcare-takes-UZWR7a7S</link>
      <enclosure length="42921526" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/805fe07d-ab0e-4e89-a6cb-474b4e479c28/audio/b339cdca-be52-45b1-9c46-e9cc35b7b0cd/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 6: Nikhil Krishnan on Doctor Influencers and Healthcare Hot Takes</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:44:42</itunes:duration>
      <itunes:summary>Jacob sits down with Nikhil Krishnan, founder of Out of Pocket, to discuss his path to becoming a healthcare meme king and the community he&apos;s building to get more people into healthcare and make it easier to start health tech businesses. They also hit on Nikhil’s thoughts on physician payment, big tech in healthcare and more.  </itunes:summary>
      <itunes:subtitle>Jacob sits down with Nikhil Krishnan, founder of Out of Pocket, to discuss his path to becoming a healthcare meme king and the community he&apos;s building to get more people into healthcare and make it easier to start health tech businesses. They also hit on Nikhil’s thoughts on physician payment, big tech in healthcare and more.  </itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>6</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">507f337b-c771-4188-a893-0d132a40d8ad</guid>
      <title>Ep 5: Lucia Huang on Psychedelic Medicine and the Future of Mental Healthcare</title>
      <description><![CDATA[Jacob sits down with Lucia Huang, co-founder and CEO of Osmind, to discuss new psychedelic and neuromodulation mental health treatments, how Osmind is furthering research around them, and what’s next for the space. 
 
]]></description>
      <pubDate>Wed, 31 Aug 2022 13:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-5-lucia-huang-XP08iEsN</link>
      <enclosure length="33041389" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/a27c556f-1e86-47a3-b5a9-42e9fda73279/audio/cdc8a67a-b50c-4cb4-9045-3ddce7549a4a/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 5: Lucia Huang on Psychedelic Medicine and the Future of Mental Healthcare</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:34:25</itunes:duration>
      <itunes:summary>Jacob sits down with Lucia Huang, co-founder and CEO of Osmind, to discuss new psychedelic and neuromodulation mental health treatments, how Osmind is furthering research around them, and what’s next for the space. 
</itunes:summary>
      <itunes:subtitle>Jacob sits down with Lucia Huang, co-founder and CEO of Osmind, to discuss new psychedelic and neuromodulation mental health treatments, how Osmind is furthering research around them, and what’s next for the space. 
</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>5</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">7712ba7b-f0e4-4f24-913f-95e645d8aa9a</guid>
      <title>Ep 4: Brad Smith on Improving Policy and Rural Healthcare</title>
      <description><![CDATA[Jacob sits down with Brad Smith, founder of CareBridge, Main Street Health and Aspire and former head of CMMI, to discuss the novel ways he’s bringing risk-based models to rural healthcare and Medicaid and hear why he thinks CMMI programs haven’t worked to date. 
]]></description>
      <pubDate>Tue, 16 Aug 2022 13:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Redpoint Ventures)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-4-brad-smith-on-improving-policy-and-rural-healthcare-JR_zDF8e</link>
      <enclosure length="37661510" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/98e6c96a-9c85-4bf8-a9b5-bbf78b188648/audio/96f84a40-3d18-406b-82a1-2e2867d3f12e/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 4: Brad Smith on Improving Policy and Rural Healthcare</itunes:title>
      <itunes:author>Redpoint Ventures</itunes:author>
      <itunes:duration>00:39:13</itunes:duration>
      <itunes:summary>Jacob sits down with Brad Smith, founder of CareBridge, Main Street Health and Aspire and former head of CMMI, to discuss the novel ways he’s bringing risk-based models to rural healthcare and Medicaid and hear why he thinks CMMI programs haven’t worked to date.</itunes:summary>
      <itunes:subtitle>Jacob sits down with Brad Smith, founder of CareBridge, Main Street Health and Aspire and former head of CMMI, to discuss the novel ways he’s bringing risk-based models to rural healthcare and Medicaid and hear why he thinks CMMI programs haven’t worked to date.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>4</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">86100898-e582-4c61-a2c0-8a311cb719c4</guid>
      <title>Ep 3: Dr. Tom Lee on Amazon/One Medical, Galileo and Healthcare&apos;s Future</title>
      <description><![CDATA[Jacob sits down with Dr. Tom Lee founder of One Medical, Galileo and Epocrates. They discuss Amazon’s $3.9B acquisition of One Medical, what Tom’s building at Galileo and the future of medical education. 
]]></description>
      <pubDate>Wed, 3 Aug 2022 13:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Tom Lee, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-3-dr-tom-lee-on-amazon-one-medical-galileo-and-healthcares-future-L9vVqSFO</link>
      <enclosure length="39613379" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/98796b13-ec5b-41b3-aded-1c5002c3ccf5/audio/1654df90-f053-4eb1-86bf-dabd15e25e84/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 3: Dr. Tom Lee on Amazon/One Medical, Galileo and Healthcare&apos;s Future</itunes:title>
      <itunes:author>Tom Lee, Jacob Effron</itunes:author>
      <itunes:duration>00:41:15</itunes:duration>
      <itunes:summary>Jacob sits down with Dr. Tom Lee founder of One Medical, Galileo and Epocrates. They discuss Amazon’s $3.9B acquisition of One Medical, what Tom’s building at Galileo and the future of medical education.</itunes:summary>
      <itunes:subtitle>Jacob sits down with Dr. Tom Lee founder of One Medical, Galileo and Epocrates. They discuss Amazon’s $3.9B acquisition of One Medical, what Tom’s building at Galileo and the future of medical education.</itunes:subtitle>
      <itunes:keywords>healthcare, vital signs, one medical, galileo, tom lee, redpoint ventures, jacob effron</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>3</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">01b1dda6-ac6c-49d9-8d91-eec50031faca</guid>
      <title>Ep 2: Dr. Mandy Cohen on Medicaid Innovation and Succeeding Under Risk</title>
      <description><![CDATA[Jacob sits down with Dr. Mandy Cohen - former Secretary of North Carolina’s Department of Health and Human Services, COO of the Center for Medicare & Medicaid Services and current CEO of Aledade’s newest business line Aledade Care Solutions. They discuss her work in North Carolina around Social Determinants of Health, how Medicaid policy and innovation works, the new business line she’s building at Aledade and what’s required for primary care practices to succeed under risk.
 
]]></description>
      <pubDate>Tue, 19 Jul 2022 13:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Mandy Cohen, Vital Signs, Redpoint Ventures, Redpoint, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/ep-2-dr-mandy-cohen-RL4eVnwE</link>
      <enclosure length="29350809" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/ce583295-6059-434e-bc90-f7d3f7ef2923/audio/84476396-9dcf-4a7a-9fe5-df30a31224f4/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 2: Dr. Mandy Cohen on Medicaid Innovation and Succeeding Under Risk</itunes:title>
      <itunes:author>Mandy Cohen, Vital Signs, Redpoint Ventures, Redpoint, Jacob Effron</itunes:author>
      <itunes:duration>00:30:34</itunes:duration>
      <itunes:summary>Jacob sits down with Dr. Mandy Cohen - former Secretary of North Carolina’s Department of Health and Human Services, COO of the Center for Medicare &amp; Medicaid Services and current CEO of Aledade’s newest business line Aledade Care Solutions. They discuss her work in North Carolina around Social Determinants of Health, how Medicaid policy and innovation works, the new business line she’s building at Aledade and what’s required for primary care practices to succeed under risk.
</itunes:summary>
      <itunes:subtitle>Jacob sits down with Dr. Mandy Cohen - former Secretary of North Carolina’s Department of Health and Human Services, COO of the Center for Medicare &amp; Medicaid Services and current CEO of Aledade’s newest business line Aledade Care Solutions. They discuss her work in North Carolina around Social Determinants of Health, how Medicaid policy and innovation works, the new business line she’s building at Aledade and what’s required for primary care practices to succeed under risk.
</itunes:subtitle>
      <itunes:keywords>mandy cohen, redpoint, redpoint ventures</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>2</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">aa7ab99f-176a-4af3-8c6b-35ab4bb75075</guid>
      <title>Ep 1: Adam Boehler on the Value Based Care Market and What&apos;s Next</title>
      <description><![CDATA[Jacob sits down with Adam Boehler - former CEO of Landmark Health, Head of the Center for Medicare and Medicaid Innovation and current CEO of Rubicon Founders. They discuss how building a value-based care business has changed, how Adam came up with the idea for Landmark and his other businesses, what makes different patient segments a fit for value-based models and where the space is headed. They also touch on Adam's hopes for future policy and the changes he’s seen in healthcare talent. 
]]></description>
      <pubDate>Tue, 5 Jul 2022 16:00:00 +0000</pubDate>
      <author>jeffron@redpoint.com (Adam Boehler, Jacob Effron)</author>
      <link>https://vital-signs-e526bbac.simplecast.com/episodes/interview-with-adam-boehler-h_bK7f_j</link>
      <enclosure length="70701974" type="audio/mpeg" url="https://cdn.simplecast.com/audio/52447fe7-b12b-4a5c-9dea-95b1eae7c423/episodes/11129a1c-b8eb-4bfb-b504-a05f1a75cc02/audio/919ece7a-5c6f-4d25-b7a1-913519a38408/default_tc.mp3?aid=rss_feed&amp;feed=CC7kJR0I"/>
      <itunes:title>Ep 1: Adam Boehler on the Value Based Care Market and What&apos;s Next</itunes:title>
      <itunes:author>Adam Boehler, Jacob Effron</itunes:author>
      <itunes:duration>00:29:27</itunes:duration>
      <itunes:summary>Jacob sits down with Adam Boehler - former CEO of Landmark Health, Head of the Center for Medicare and Medicaid Innovation and current CEO of Rubicon Founders. They discuss how building a value-based care business has changed, how Adam came up with the idea for Landmark and his other businesses, what makes different patient segments a fit for value-based models and where the space is headed. They also touch on Adam&apos;s hopes for future policy and the changes he’s seen in healthcare talent.</itunes:summary>
      <itunes:subtitle>Jacob sits down with Adam Boehler - former CEO of Landmark Health, Head of the Center for Medicare and Medicaid Innovation and current CEO of Rubicon Founders. They discuss how building a value-based care business has changed, how Adam came up with the idea for Landmark and his other businesses, what makes different patient segments a fit for value-based models and where the space is headed. They also touch on Adam&apos;s hopes for future policy and the changes he’s seen in healthcare talent.</itunes:subtitle>
      <itunes:keywords>healthcare, adam boehler, redpoint ventures, jacob effron, healthtech, venture capital, at home care</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
    </item>
  </channel>
</rss>